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1.1 The renal ion channels 
There are many proteins embedded in cell membranes. Ion channels are one 
class of such molecules and provide pores for the passive diffusion of ions 
across biological membranes. They are often highly selective for a particular 
ionic species, leading to a classification into sodium (Na+), potassium (K+), 
calcium (Ca2+), chloride (CI-) and unspecific cation channels. 
Epithelial cells in the kidney perform vectorial transport of Na +, K+, Ca2+, Cl- and 
water. These processes are mediated by a number of channels and pumps, and 
play a vital role in the maintenance of the ionic composition of the extracellular 
fluid compartment. A variety of hormones, amongst these the adrenal 
mineralocorticoid aldosterone, regulate renal ion and water transport functions  
(Loffing et al., 2001b). 
 
1.2 The renal epithelial K+ channels ROMK (Kir1.1) 
 
1.2.1 Physiological roles of ROMK channels in the kidney 
Intracellular K+ (approximately 145 mM) represents the major portion of total 
body K+. The K+ concentration in the extracellular fluid ranges from 3.5-5 mM. 
To maintain a constant serum K+ level, 95% of dietary K+ absorbed from the 
intestine is excreted through the kidney and the remaining portion is eliminated 
via the colon (Thier, 1986; Stanton, 1989). Under pathophysiological conditions 
like chronic renal failure, colonic excretion is increased and can contribute  
significantly to K+ homeostasis (Martin et al., 1986). 
K+ secretion in the kidney is a very complex process depending on flow rate, 
luminal K+, Na+ and Cl- concentrations, hormones and the acid-base status 
(Stanton, 1989; Wang, 1995; Giebisch, 1998). 
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Fig. 1. Apical ROMK channels mediate potassium secretion and regulate 
NaCl reabsorption in the kidney (adapted from Hunter, 2001). (A) Salt 
reabsorption in tubular cells of the thick ascending limb of Henle 
(TALH); left (luminal side): apical membrane with NKCC2 cotransporter 
and ROMK1 channels; right: basolateral membrane with Na+,K+-
ATPase and CIC-Kb channels. (B) K+ secretion in principal cells of the  
distal convoluted tubule and cortical collecting duct; left (luminal side): 
apical membrane with ROMK1 channels and ENaC channels; right: 
basolateral membrane with Na+,K+-ATPase. Arrows indicate the 
direction of ion fluxes under physiological conditions. 
 
In the thick ascending limb of Henle’s loop, K+ participates in the reabsorption of 
NaCl from the primary urine (Hebert and Andreoli, 1984; Bleich et al., 1990; 
Wang et al., 1990a, b) as illustrated in Fig. 1A. Luminal Na+, K+ and Cl- enter 
the tubular cells via the furosemide-sensitive Na+-K+-2Cl- cotransporter 
(NKCC2). This process depends on K+ efflux through apical K+ channels ROMK 
(Kir1.1), which allow recycling of luminal K+ (Hebert, 1998). Cl- and Na+ are 
eliminated from the cells by cAMP-dependent Cl- channels (ClC-Kb) and 
Na+,K+-ATPase in the basolateral membrane, respectively (Giebisch, 1998; 
Köckerling et al., 1998). 
K+ secretion (Fig. 1B) is mediated by principal cells in the distal tubules and 
cortical collecting duct (Wang, 1995; Köckerling et al., 1998). Na + influx through 
amiloride-sensitive epithelial Na+ channels (ENaC) in the apical membrane is 
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rate limiting for K+ excretion. The driving force for Na+ influx is generated by the 
action of basolateral Na+,K+-ATPase which also provides the necessary K+ 
gradient. Both Na+ reabsorption and K+ secretion are stimulated by aldosterone. 
This hormone was shown to increase the apical Na+ conductance within hours 
and to up-regulate expression of ENaC and Na+,K+-ATPase (O'Neil, 1990). 
Intercalated cells (not shown), which constitute the second type of epithelial 
cells in these nephron segments, partially reabsorb urinary K+ via H+,K+-ATPase 
(Graber and Pastoriza-Munoz, 1993; Giebisch, 1998). 
K+ secretion in the distal tubule is mediated by intermediate conductance (35-39 
pS) weak inward-rectifier K+ channels (Wang et al., 1990a, b, 1992, 1994). 
Their activity has been shown to be linked to basolateral Na+,K+-ATPase by a 
pathway involving ion exchange, Ca2+ and protein kinase C (PKC) (Wang et al., 
1993). In addition to regulation by protein kinases (Wang and Giebisch, 1991b), 
they have been shown to be particularly sensitive to changes in intracellular pH 
(pHi) (Wang et al., 1990a, b; Wang and Giebisch, 1991a). Intracellular 
acidification in the physiological range reversibly reduced channel open 
probability (Wang et al., 1990a, b). An inward-rectifier K+ channel (31 pS) with a 
similar sensitivity to pHi has been characterized in luminal membranes of the 
thick ascending limb of Henle’s loop (Bleich et al., 1990). 
These functional properties together with immunocytochemical data (Xu et al., 
1997) confirmed that ROMK (Kir1.1) channels underly the K+ conductance 
involved in renal salt reabsorption and K+ secretion. 
 
1.2.2 Alternative splicing of the romk (Kir1.1 or KCNJ1) gene 
ROMK (Kir1.1) was originally cloned from a rat kidney cDNA library (Ho et al., 
1993) as a member of the inward-rectifier (Kir) family of K+ channels (Nichola 
and Lopatin, 1997) encoded by the romk (Kir1.1 or KCNJ1) gene (Lu et al., 
2002). Genomic analysis revealed that rat and human romk genes contain 6 
exons, which are spliced alternatively to yield various ROMK isoforms (Shuck et 
al., 1994; Yano et al., 1994; Boim et al., 1995; Kondo et al., 1996; Beesley et 
al., 1999) as indicated in Fig. 2. Since exon 6 (core) encodes the major part of 
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the channel protein, splicing results primarily in variable length of the NH2-
terminus. ROMK2 (K ir1.1b) is shortened by 19 amino acids, and ROMK3 
(Kir1.1c) is extended by 7 amino acids compared to ROMK1 (K ir1.1a). 
 
r-& h-ROMK1
r-& h-ROMK2
r-& h-ROMK3
h-ROMK4
h-ROMK5
r-ROMK6
exons 1 2 3 4 5 Core (6)
coding non-coding coding, with an in-frame stop codon
 
 
Fig. 2. Structure of the rat and human romk genes encoding various ROMK 
isoforms (adapted from Kondo et al., 1996). Alternative splicing of the 
romk gene yields 6 different ROMK mRNAs. Exons 2 and 4 code for 
different NH2-termini in ROMK3 (Kir1.1c) and ROMK1 (K ir1.1a), 
respectively. Exons 1, 3 and 5 do not contribute to the primary structure 
of ROMK subunits. Exon 6 (core) encodes ROMK2 (Kir1.1b) and the 
major part of the other K ir1.1 splice variants. 
 
ROMK1 as well as the other splice variants are differentially expressed along 
the nephron in the kidney (Frindt and Palmer, 1989; Wang et al., 1990a, b; 
Zhou et al., 1994; Boim et al., 1995; Lee and Hebert, 1995), with the exception 
of ROMK6 (Kir1.1f), which is ubiquitously transcribed in various tissues including 
kidney, brain, heart, liver, pancreas and skeletal muscle (Kondo et al., 1996). 
Up to date, no functional differences could be observed between Kir1.1 isoforms 
when expressed in Xenopus oocytes. Thus, all Kir1.1 experiments in this study 
were carried out with the rROMK1 (K ir1.1a). 
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1.2.3 Molecular structure 
ROMK belongs to a family of structurally and functionally related K+ channels  
designated as Kir channels (Doupnik et al., 1995). The membrane topology and 
secondary structure of Kir channels has been predicted from hydropathy plots of 
their primary amino acid sequence and investigated by detailed mutagenesis 
(Ben-Efraim and Shai, 1996, 1997). Two hydrophobic segments, M1 and M2, 
form membrane spanning domains and flank a stretch of amino acids that is 
highly homologous to the H5 region of voltage-gated K+ channels known as the 
P (pore) region which contains the putative channel pore (Fig. 3).  NH2- and 
COOH-termini are thought to be located in the cytoplasm, although a partial 
association with the membrane can not be excluded. There is experimental 
evidence that parts of the COOH-terminus contribute to the intracellular 
vestibule of the pore (Taglialatela et al., 1994; Baukrowitz et al., 1999). The last 
three amino acids (389-391) (TQM, where T is threonine, Q is glutamine, and M 
is methionine) in the COOH-terminus form a type 1 PDZ binding motif (X-S/T-X-
I/V/L/M, where X is any amino acid, S is serine, T is threonine, I is isoleucine, V 
is valine, L is leucine, and M is methionine) which is necessary for high affinity 
interaction with the PDZ domain of the NHERF proteins (Fanning and 
Anderson, 1996). 
Several potential phosphorylation sites for both protein kinase A (PKA) and 
protein kinase C (PKC) are present on the predicated ROMK1 channel protein. 
All three protein kinase A (PKA) phospho-acceptor sites in ROMK1, embedded 
within the cytoplasmic NH2- (Ser-44) and COOH-termini (Ser-219 and Ser-313), 
must be phosphorylated for full channel function (MacGregor et al., 1998). 
Close inspection of the NH2-terminal PKA site in ROMK1 reveals that it also 
falls within a canonical serum and glucocorticoid inducible kinase (SGK1) 
phosphorylation sequence (recognized by a R-X-R-X-X-S/T, where R is 
arginine, X is any amino acid, S is serine, and T is threonine) (Kobayashi and 
Cohen, 1999b; Park et al., 1999), suggesting that the channel, and serine 44 in 
particular, might also be a target of SGK1 (Yoo et al., 2003). 
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Fig. 3. Structural model of the ROMK channel (adapted from Wang et al., 
1997). ROMK is formed by two transmembrane-spanning domains (M1 
and M2) which flank a stretch of amino acids that is highly homologous 
to the H5 region of voltage-gated K+ channels known as the P-region. 
The intracytoplasmic amino- and carboxy-terminal tails contain several 
potential regulatory domains, including several potential protein kinase 
A (PKA) and protein kinase C (PKC) phosphorylation sites as well as 
putative PDZ binding motif. 
 
1.2.4 Physiological regulation of channel activity 
Tsai and colleagues showed that Kir1.1 channels are particularly sensitive to 
changes in intracellular pH (pHi) (Tsai et al., 1995). pHi did not affect the single 
channel current amplitude, but a decrease in channel open probability upon 
acidification (Fakler et al., 1996; Choe et al., 1997; McNicholas et al., 1998). 
The steady-state current-pHi relation showed a pHi value for half maximal 
activation (pKapp) of 6.9 and a Hill coefficient of around 3 indicating cooperativity 
of the gating process. Binding of K+ ions to an extracellular site has been shown 
to be essential for Kir1.1 channel activity but not for that of other Kir channels 
(Doi et al., 1996). The halfmaximal K+ concentration determined in whole-cell 
experiments was around 4.5 mM but shifted to higher values when the 
intracellular pH was decreased. 
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Binding of the negatively charged phospholipid phosphatidylinositol 4,5-
bisphosphate (PIP2) appears to be a general property of Kir channels 
(Hilgemann and Ball, 1996; Huang et al., 1998), and has also been reported for 
Kir1.1. Fusion proteins constructed from the Kir1.1 COOH-terminus bound PIP2 
in vitro, and the presence of PIP2 was shown to be necessary for Kir1.1 channel 
activity (Huang et al., 1998). 
Indeed, regulatory phosphorylation by PKA has been demonstrated for Kir1.1 
channels in renal epithelial cells (McNicholas et al., 1994) and biochemically 
verified in detail (Xu et al., 1996). It is possibly facilitated by A-kinase-
associated proteins (Ali et al., 1998). In fact, activation of ROMK by PKA is 
thought to underlie the regulation of renal potassium transport by vasopressin 
(Cassola et al., 1993). In addition, ROMK is a substrate of PKC and serine 
residues 4 and 201 are the two main PKC phosphorylation sites that are 
essential for the expression of ROMK in the cell surface (Lin et al., 2002). 
Finally, aldosterone, vasopressin, and other factors precisely regulate ROMK 
activity, controlling potassium excretion in accord with the demands of 
potassium balance (Giebisch, 1998; Palmer, 1999; Gallazzini et al., 2003). 
Because ROMK channels normally exhibit a very high open probability near 
unity, physiologic augmentation of channel activity, as controlled by hormones 
and dietary potassium (Wang et al., 1992), is achieved largely by regulated 
changes in the number of active channels in the plasmalemma. 
 
1.2.5 The antenatal Bartter Syndrome (aBS) 
Hereditary renal tubular disorders leading to severe salt wasting and impaired 
urinary concentrating ability are rare diseases with an incidence of 
approximately 1: 50000 newborns. The first patients have been described by 
Bartter and colleagues with symptoms of excessive renal salt loss, 
hyperreninism, hyperaldosteronism with low or normal blood pressure, 
hypokalemic metabolic alkalosis, decreased pressor responsiveness to infused 
angiotensin II, and hyperplasia of the juxtaglomerular complex (Bartter et al., 
1962, 1998). 
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In the following years, cases showing variants of this syndrome were reported 
by several groups (Gitelman et al., 1966; Fanconi et al., 1971; Seyberth et al., 
1985; International collaborative study group for Bartter-like syndromes, 1997; 
Feldmann et al., 1998). Currently, at least three types with biochemical and 
physiological characteristics that are similar to those resulting from long-term 
application of certain diuretics can be distinguished (Seyberth et al., 1987, 
1997; Köckerling et al., 1998): 
· Bartter syndrome type I and II (antenatal (neonatal) Bartter Syndrome) 
(aBS), more correctly termed Hyperprostaglandin E-Syndrome (HPS; 
(Konrad et al., 1999)) or FSLT (furosemide-like salt-losing tubulopathy). 
· Gitelman Syndrome; synonyms: Hypocalciuric Bartter Syndrome or TSLT 
(thiazide-like salt-losing tubulopathy). 
· “Classic” Bartter syndrome or Bartter syndrome type III (Rodriguez-
Soriano, 1998). 
This classification was confirmed by identification of the genes underlying these 
defects. Five genes have been identified as causing Bartter syndrome, with the 
unifying pathophysiology being the loss of salt transport by the thick ascending 
limb. Phenotypic differences in Bartter types relate to the specific physiological 
roles of the individual genes in the kidney and other organ systems (Hebert, 
2003). Mutations at the gene encoding for the thiazide-sensitive Na+-Cl- 
cotransporter (NCCT or SLC12A3) of the renal distal convoluted tubule were 
found in the majority of patients with Gitelman syndrome (Simon et al., 1996a). 
The most severe form, aBS, is genetically heterogeneous: Mutations either at 
the gene encoding the furosemide-sensitive Na+-K+-2Cl- cotransporter (NKCC2 
or SLC12A1) or the gene encoding an ATP-sensitive inwardly rectifying 
potassium channel (ROMK or KCNJ1) of the medullary thick ascending limb 
(mTAL) of the Henle’s loop have been identified in aBS (type I and type II, 
respectively) patients (Simon et al., 1996b). Recently, either deletions or 
mutations at the gene encoding a renal chloride channel (CLC-Kb) have been 
identified in the majority of patients with “Classic” Bartter syndrome. Also loss-
of-function mutations in the BSND gene, which encodes the integral membrane 
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protein barttin thus cause Bartter syndrome with sensorineural deafness and 
renal failure (Birkenhäger et al., 2001; Hebert, 2003). 
Antenatal (neonatal) Bartter Syndrome (aBS) is inherited as an autosomal 
recessive entity. Mutations of romk gene appear to be rare, since the gene 
shows little allelic variation in the healthy population and most identified 
mutations are unique for single patients. Typically, affected children are 
compound heterozygous, i.e. they harbour a different mutation on either romk 
gene. Point mutations linked to aBS are apparently distributed over the whole 
coding region of the gene. 
The molecular mechanisms leading to impairment or loss of Kir1.1 channel 
function are yet unknown. A major pathophysiological consequence seems to 
be the impairment of NaCl reabsorption in the ascending loop of Henle which 
depends on K+ recycling through Kir1.1 channels  ((Hebert, 1998), see also Fig. 
1A). The resulting loss of salt and fluid leads to polyhydramnios and premature 
delivery due to intrauterine polyuria (Seyberth et al., 1997). Polyuria remains 
life-threatening in young children if they are not treated by substitution with fluid, 
NaCl and KCl. Prostaglandin E2 (PGE2) is markedly elevated and plays an 
important role in the pathogenesis as it aggravates salt and fluid loss. Renin 
and aldosterone levels are also increased, but are insufficient to counteract the 
loss of NaCl, as Na+ reabsorption by principal cells in the distal tubulus depends 
on the presence of functional Kir1.1 channels in the apical membrane (Fig. 1B). 
Other secondary symptoms are hypercalciuria, which may lead to 
nephrocalcinosis, and alkalosis possibly resulting from excessive H+/K+ 
exchange in the collecting duct to reduce K+ loss (Seyberth et al., 1985, 1997; 
Köckerling et al., 1998). 
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1.3 The renal epithelial Ca2+ channel ECaC1 (TRPV5) 
 
1.3.1 Physiological roles of ECaC1 in the kidney 
As depicted in Fig. 4, ECaC1 mediates the first step of Ca2+ reabsorption in the 
cortical collecting duct. The transported Ca2+ binds to calbindin-D28K (CaBP28K) 
and diffuses through the cytosol to the basolateral membrane, where Ca2+ is 
then extruded through the Na+/Ca2+ exchanger (NCX1) and plasma membrane 
Ca2+-ATPase (PMCA1b) (Hoenderop et al., 2002). 
 
ATP
ADP
3Na+
Ca2+-ATPase
ECaC1
Na+/Ca2+ exchanger
Ca2+
Ca2+Ca2+
CaBP28K
Distal part of the nephron
apical basolateral
 
 
Fig. 4. Transcellular Ca2+ transport in cells lining the distal part of the 
nephron (adapted from Hoenderop et al., 2000a). Entry of Ca2+ is 
facilitated by the apical Ca2+ channel ECaC1 (TRPV5). Subsequently, 
the ion binds to calbindin-D28K (CaBP28K) and diffuses through the 
cytosol to the basolateral membrane. Here, Ca2+ ions are extruded by a 
Na+/Ca2+ exchanger (NCX1) and a Ca2+-ATPase (PMCA1b). 
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1.3.2 Genomic structures of ECAC1 and ECAC2 genes 
The epithelial calcium channel ECaC has been cloned recently from rabbit 
kidney by Hoenderop and co-workers using functional expression cloning 
strategy based on cDNA library generated from a Ca2+ transporting primary 
culture of rabbit connecting tubules (Hoenderop et al., 1999a). Genomic 
analysis revealed that the ECAC gene contains 15 exons and 4 putative vitamin 
D-responsive elements (VDREs) (Müller et al., 2000) as depicted in Fig. 5. More 
recently, human (Müller et al., 2000) and rat ECaC1 (Peng et al., 2000; 
Hoenderop et al., 2000b) have been characterized. 
Another type of ECaC, expressed in the intestine, has been cloned from rabbit 
(Hoenderop et al., 2000c), rat (CaT1) (Peng et al., 1999) and human (Barley et 
al., 2001) which has been designated to ECaC2. Wissenbach and co-workers 
(2001) have additionaly cloned the human ECaC2 expressed in the placenta 
(CaT2). 
 
exons 1 2 3 4 5 6 7 8 910 11 12 13 14 15
exons 1 2 3 4 5 6 7 8 91011121314 15
ECaC1
ECaC2
Start Codon (ATG) Stop Codon (TAA)
 
 
Fig. 5. Genomic structures of ECAC1 and ECAC2 (adapted from Weber et al., 
2001). Exons (dark blue boxes) and introns (black lines). 
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1.3.3 Molecular structure 
The epithelial calcium channel ECaC1 is a member of the osmosensitive, 
transient receptor potential channel (OTRPC) family that comprises several 
types of Ca2+-permeable cation channels (Harteneck et al., 2000), including the 
vanilloid receptor 1 (VR1) and the vanilloid receptor-like channel 1 (VRL1). 
ECaC1 shows similarity with all these channels (Birnbaumer et al., 1996; 
Caterina et al., 1999; Hoenderop et al., 2000a; Nilius et al., 2001a) according to 
the predicted topology showing six transmembrane domains with a putative 
loop pore between transmembrane segment 5 and 6 (Fig. 6). However, ECaC1 
exhibits only 30% homology with those channels, indicating that ECaC1 is 
considered to be the first member of a new class of Ca2+ channels within this 
family (Hoenderop et al., 2000b). 
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Fig. 6. Proposed topology of the ECaC1 protein (adapted from Hoenderop et 
al., 2002). Consisting of six transmembrane-spanning domains with a 
stretch of amino acids that is highly homologous to the H5- or P-region 
between transmembrane segment 5 and 6. Cystosolic NH2- and COOH-
terminal tails containing several potential regulatory domains, including 
ankyrin repeats, PDZ binding motifs, and sites for PKC phosphorylation. 
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1.3.4 Physiological regulation of channel activity 
Ca2+ transport in the distal nephron plays a key role in the fine regulation of 
extracellular Ca2+concentration. It is therefore the target of environmental and 
hormonal regulation. For instance, ECaC1 is stimulated by extracellular pH and 
intracellular calcium (Vennekens et al., 2001; Nilius et al., 2001b). Moreover, 
1,25(OH)2D3, an active metabolite of vitamin D, has been reported to stimulate 
Ca2+ reabsorption in the distal nephron (Bindels et al., 1991; Hoenderop et al., 
2000a; Suki and Rose, 1996; van Baal et al., 1996). This stimulating effect is 
accomplished by up-regulation of calbindin-D28K (Christakos et al., 1989; 
Hunziker and Schrickel, 1988) and most recently by stimulation of ECaC 
(Hoenderop et al., 2001a). It has been revealed that the human ECaC promotor 
contains indeed four putative vitamin D-responsive elements (Hoenderop et al., 
2001a; Müller et al., 2000). 
In addition, parathyroid hormone (PTH) has been revealed to stimulate the 
active Ca2+ transport in the distal convoluted tubule (DCT) as well as in the 
connecting tubule (CNT) (Bindels et al., 1991; Friedman and Gesek, 1995; 
Hoenderop et al., 2000a). This stimulatory effect is mediated by coupling of the 
PTH receptor to both adenyl cyclase and phospholipase C which in turn can 
activate cAMP and PKC signaling cascades (Friedman and Gesek, 1995; 
Hoenderop et al., 1999b). ECaC1 contains indeed several conserved sites for 
PKC phosphorylation suggesting that ECaC1 could be a target of PTH 
regulation (Hoenderop et al., 2002). 
The natriuretic effect of thiazide, the inhibitor of the apical Na+-Cl- cotransporter 
(NCC) expressed in the distal convoluted tubule, has been shown to be 
accompanied by hypocalciuria (Sutton et al., 1979). Several findings have been 
gathered to elucidate such inverse relationships betweeen Na + and Ca2+ 
reabsorption. One hypothesis is that NCC inhibition results in hyperpolarization 
due to decrease of the intracellular Cl- activity. Consequently, apical Ca2+ entry 
will be enhanced (Friedman, 1998). ECaC1 accordingly becomes a good 
candidate for regulation since its activity reaches a maximal value during 
hyperpolarization (Hoenderop et al., 1999c; Vennekens et al., 2000). However, 
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this notion is not convincingly supported by several experiments (Friedman, 
1998). In theory, the basolateral Na+/Ca2+ exchanger (NCX1) could be 
alternatively involved since thiazide induced natriuresis results in reduction of 
the intracellular Na+ concentration and thus to inhibition of Ca2+ efflux. However, 
several lines of evidence show only little overlap of NCX1 and NCC (Hoenderop 
et al., 2000c; Hoenderop et al., 2001a; Loffing et al., 2001a). 
Finally, the identification of ECaC1 merits more interest, since it could underlie 
the idiopahtic hypercalciuria (Müller et al., 2002). 
 
1.3.5 Clinical implications of ECaC1 channel regulation 
The epithelial calcium channel ECaC1 represents the molecular basis of the 
apical Ca2+ entry step in transcellular Ca2+ reabsorption. Because this pathway 
allows the body to actively regulate the net amount of Ca2+ leaving the body, the 
delineation of the molecular mechanisms involved in its regulation could provide 
new insights in disturbances of Ca2+ homeostasis (Hoenderop et al., 2002). 
The identification of ECaC1 shed new light on Ca2+ homeostasis-related 
disorders (Hoenderop et al., 2000b). The epithelial calcium channel involved in 
multifactorial pathogenesis of disorders such as idiopathic hypercalciuria, 
kidney stone disease, postmenopausal osteoporosis and the hypocalciuria in 
chronic thiazide treatment and Gitelman’s syndrome (Nijenhuis et al., 2003). 
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1.4 The renal CIC-K/barttin chloride channels 
 
1.4.1 Expression pattern and physiological functions 
Within the kidney, ClC-K1 was located predominantly in the thin ascending limb 
of Henle’s loop (Uchida et al., 1993), a nephron segment known for its high Cl- 
permeability. ClC-K1 appeared to be expressed in both apical and basolateral 
membranes (Uchida et al., 1995). In contrast, another study using an antibody 
that recognized both ClC-K1 and ClC-K2 (Vandewalle et al., 1997) found 
exclusive labeling of basolateral membranes in the late nephron segments. 
Proximal tubules and glomerula were not stained, but the thin ascending limb, 
the medullary and cortical thick ascending limb of Henle’s loop, as well as the 
distal convoluted tubule and intercalated cells of the cortical collecting duct were 
labeled (Vandewalle et al., 1997; Estévez et al., 2001). 
The assumption that the staining of the thin ascending loop is exclusively due to 
ClC-K1 (Uchida et al., 1995; Matsumura et al., 1999) indicated that ClC-K2 is 
present along the thick ascending limb, the distal convoluted tubule, and even in 
downstream segments of the nephron (Vandewalle et al., 1997). These results 
were largely confirmed by in situ hybridization (Yoshikawa et al., 1999). An 
antibody directed against a rabbit ClC-K isoform (rbClC-Ka) inhibited 36Cl efflux 
from rabbit medullary thick ascending limbs in suspension (Winters et al., 1997). 
However, the significance of this finding is not clear, as the antibody, which was 
raised against an intracellular epitope, was added extracellularly. 
Staining of the b-subunit barttin shows a complete overlap with ClC-K 
expression (Estévez et al., 2001), indicating that it forms heteromers with both 
ClC-K1 and ClC-K2. This applies also for the inner ear, where staining with ClC-
K antibodies (Estévez et al., 2001; Sage and Marcus, 2001) and with barttin 
show complete overlap in basolateral membranes of the Stria vascularis and 
dark cells of the vestibular organ (Estévez et al., 2001). Both cell types are 
involved in K+ secretion. 
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As ClC-K1 and ClC-K2 mRNA could both be detected in cochlear RNA (Estévez 
et al., 2001), it was concluded that both a-subunits combine with barttin in 
marginal cells of the Stria vascularis. Patch-clamping of marginal cells revealed 
indeed Cl- currents that resembled ClC-K currents in their voltage dependence, 
ion selectivity, and sensitivity to extracellular pH and Ca2+ concentration (Ando 
and Takeuchi, 2000). As depicted in Fig. 7, CIC-K chloride channels participate 
in transepithelial CI- transport in the kidney and inner ear (Estévez et al., 2001). 
 
Cells of the  
stria vascularis 
KCNQ1/
KCNE1
K+
ATP
ADP
Na+
K+
Na+,K+-ATPase
CI-
CI-
Na+
K+
NKCC1
CIC-Kb
CI-
CIC-Ka
CI-
B
Ascending loop
of Henle
CI-
CI-
Na+
K+
NKCC2
ATP
ADP
Na+
K+
Na+,K+-ATPase
ROMK1
K+
CIC-Kb
CI-
K+
A
lumen blood endolymph interstitium
 
 
Fig. 7. CIC-K/barttin heteromers function in transepithelial transport in 
kidney (A) and the inner ear (B) (adapted from Estévez et al., 2001). 
(A) In cells of the renal thick ascending limb, apical NKCC2 
cotransporters driving Cl- uptake require ROMK1 to recycle K+. Cl- exits 
basolaterally through channels containing ClC-Kb a-subunits and 
barttin b-subunits. Mutations in all four genes cause Bartter’s 
syndrome. (B) In strial marginal cells, basolateral NKCC1 raises 
intracellular K+ concentration. In parallel, basolateral ClC-Ka/barttin and 
ClC-Kb/barttin channels recycle Cl-. K+ exits apically through channels  
containing KCNQ1 a-subunits and KCNE1 b-subunits. Loss of KCNQ1, 
KCNE1, NKCC1 or barttin causes deafness. Neither loss of ClC-K1 
(the orthologue of ClC-Ka) nor of ClC-Kb alone entails deafness. 
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1.4.2 Genomic structures of CLCNKA and CLCNKB genes 
Two members of the chloride channel gene family are predominantly expressed 
in the kidney. In the rat, these two isoforms were called ClC-K1 and ClC-K2 
(Uchida et al., 1993; Kieferle et al., 1994; Adachi et al., 1994), whereas they are 
called CLCNKA and CLCNKB in humans (Kieferle et al., 1994; Saito-Ohara et 
al., 1996). Physiological (Matsumura et al., 1999; Simon et al., 1997) and 
morphological (Kieferle et al., 1994; Uchida et al., 1995; Vandewalle et al., 
1997; Yoshikawa et al., 1999) evidence now suggests that ClC-K1 corresponds 
to CLCNKA, and ClC-K2 to CLCNKB. The gene structure analysis revealed that 
the two-chloride channel genes have identical organization, with each channel 
encoded by 19 exons as depicated in Fig. 8. The lenghths of the introns of each 
gene are generally similar. Overall, the genes show 94% DNA sequence 
identity in exons (Simon et al., 1997). 
 
exons
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Fig. 8. Organization of CLCNKA and CLCNKB genes (adapted from Simon et 
al., 1997). CLCNKA and CLCNKB have identical organization, with each 
channel encoded by nineteen exons. The lengths of the introns of each 
gene are similar. 
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1.4.3 Molecular structure 
The initial hydropathy analysis of the Torpedo channel ClC-0 indicated the 
presence of up to 13 transmembrane domains that were dubbed D1-D13 
(Jentsch et al., 1990). Domain D13 does not cross the cell membrane and both 
its carboxy- and amino-termini are located intracellularly (Gründer et al., 1992). 
Some of the domains are extracellularly located (D4) and others seem to be 
missing from certain ClC channels, based on their low hydropathy index and 
low degree of sequence conservation (Brandt and Jentsch, 1995) as indicated 
in Fig. 9. It is now clear that all ClC-K isoforms need barttin (Birkenhäger et al., 
2001), a relatively small protein (320 amino acid) with two transmembrane 
spans next to the amino-terminus, as a b-subunit in vitro and in vivo (Estévez et 
al., 2001). Interestingly, its COOH-terminus contains a PY motif (PXPPY, where 
P is proline, X is any amino acid, and Y is tyrosine). This PY motif mediates 
binding to the WW domains of Nedd4 (Chen and Sudol, 1995). 
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Fig. 9. Transmembrane topology of CIC-K/barttin channels (adapted from 
Jentsch et al., 2002). The CIC-K protein contains 12 transmembrane 
domains that were dubbed D1-D12. NH2- and COOH-termini are 
located intracellularly. The COOH-terminus has two CBS (cystathionine 
b-synthase) domains that have a so far unspecified role in protein-
protein interaction (shown at left). CIC-K proteins associate with the b-
subunit barttin, which spans the membrane twice (shown at right). 
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1.4.4 Physiological regulation of channel activity 
Renal ClC-K expression is influenced by changes in water and salt load. 
Dehydration increased transcription of ClC-K1 (Uchida et al., 1993; Vandewalle 
et al., 1997), compatible with its role in antidiuresis. 
ClC-K2 was reported to be overexpressed in the renal medulla of Dahl salt-
sensitive rats (Castrop et al., 2000). It was down-regulated by high-salt diet. To 
understand this regulation, promoters of both isoforms were isolated and 
subjected to an initial characterization (Uchida et al., 1998, 2000; Rai et al., 
1999). 
When expressed in Xenopus oocytes, rat ClC-K1 yielded anion currents with a 
moderate outward rectification that showed only little time-dependent 
relaxations. Their halide selectivity was Br- > Cl- >  I- (Uchida et al., 1998). 
Currents were decreased by extracellular acidification and by removing 
extracellular Ca2+ (Uchida et al., 1995). Increasing extracellular Ca2+ 
concentration led to further enhancement of currents, and no saturation was 
reached even at 5 mM Ca2+. 
Mg2+ and Ba2+ lacked such an effect. To obtain definitive evidence that these 
currents are mediated by ClC-K1, a valine in a highly conserved domain at the 
end of D3 was replaced by glutamate, which is found in nearly all other ClC 
channels at that position. This drastically changed gating, which now slowly 
opened the channel upon hyperpolarization. Moreover, the halide selectivity 
was changed to Cl- > Br- > I-  (Waldegger and Jentsch, 2000). 
ClC-K2 expression was reported to yield  similar, outwardly rectified currents, 
which, however, lacked the initial gating component and displayed a Br- > I- > 
Cl- selectivity (Adachi et al., 1994). Disconcertingly, a splice variant lacking 
transmembrane domain D2 gave currents with indistinguishable properties, 
suggesting that endogenous oocyte currents have been reported. 
Two groups (Kieferle et al., 1994; Zimniak et al., 1996) were initially unable to 
get currents from any ClC-K channel, including both human isoforms. While the 
expression of ClC-K1 by Uchida and colleagues (1993, 1998) could later be 
reproduced by Waldegger and Jentsch (Waldegger and Jentsch, 2000), they 
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remained unable to observe currents with ClC-K2, ClC-Kb, and surprisingly also 
with ClC-Ka. To get as close to ClC-Kb currents as possible, a series of rat ClC-
K1/human ClC-Kb chimeras was constructed. The currents from a chimera 
containing large parts of ClC-Kb differed markedly from ClC-K1. In particular, 
the Cl- > Br- > I- selectivity differed from ClC-K1. In contrast to experiments 
reported for ClC-1/ClC-3 chimeric channels (Fahlke et al., 1997), the 
transplantation of a ClC-Kb stretch between D3 and D5 did not suffice to 
impose "ClC-Kb-like" features on ClC-K1. However, a stretch from D1 to D5 
was sufficient (Waldegger and Jentsch, 2000), suggesting that pore properties 
are not "encoded" by a single small part of the protein. 
It was recently shown (Estévez et al., 2001) that both isoforms of ClC-K need 
the b-subunit barttin for proper function. Barttin strongly enhanced ClC-K1 
currents and led for the first time to measurable currents from ClC-Ka and ClC-
Kb. In combination with barttin, both ClC-Ka and -Kb currents were enhanced 
by extracelluar Ca2+ and inhibited by low extracellular pH (Estévez et al., 2001). 
The stimulation of ClC-Ka currents by barttin was due to an increased 
expression at the cell surface (Waldegger et al., 2002). Mutation in a putative 
PY motif in barttin’s carboxy-terminus increased currents, possibly indicating a 
regulation of surface expression (Estévez et al., 2001) similar to that described 
for ClC-5 (Schwake et al., 2001). 
 
1.4.5 Pathophysiological significance of ClC-K/barttin channels 
Mutations in CLCNKB underlie Classic Bartter syndrome or Bartter’s syndrome 
type III (Simon et al., 1997), strongly suggesting that ClC-Kb (and ClC-K2 in 
rodents) mediates basolateral Cl- efflux in the thick ascending limb of Henle’s 
loop. The disruption of Clcnk1 (the mouse orthologue of ClC-Ka) in mice led to 
nephrogenic diabetes insipidus (Matsumura et al., 1999), probably because it 
mediates Cl- flux across cells of the thin ascending limb of Henle’s loop (Uchida 
et al., 1995; Matsumura et al., 1999; Akizuki et al., 2001). Mutations in the 
common b-subunit barttin result in Bartter’s syndrome with sensorineural 
deafness (BSND) and kidney failure (Birkenhäger et al., 2001). 
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1.5 Serum and glucocorticoid inducible kinase and protein kinase B 
Webster and co-workers (1993) were the first to observe an increase in mRNA 
encoding a kinase in a rat mammary tumor cell line after 30 min serum and 
glucocorticoid treatment. This kinase was then named serum and glucocorticoid 
induced kinase (SGK). SGK belongs to the serine/threonine kinase gene family. 
Its catalytic domain has significant sequence homology (45-55% identity) with 
rac protein kinase, the PKC family, ribosomal protein S6 kinase, cyclic AMP-
dependent protein kinase A (PKA) (Webster et al., 1993) as well as protein 
kinase B (Kobayashi et al., 1999a). 
Human SGK was subsequently identified in a human hepatoma cell line which 
is regulated by cell shrinkage (Waldegger et al., 1997) through p38/mitogen-
activated protein kinase (MAP) kinase (Waldegger et al., 2000b). More recently, 
two additional human SGK have been cloned, termed SGK2 and SGK3, whose 
catalytic domains share 80% identity (Kobayashi et al., 1999a). SGK3 is also 
known as cytokine-independent survival kinase (CISK) since it is involved in cell 
survival through its Phox homology (PX) domain (Xu et al., 2001). Despite the 
high sequence similarity between all types of SGK, several differences are 
apparently present. SGK2 is only present at significant levels in liver, kidney 
and pancreas and only at lower levels in the brain, whereas SGK1 and SGK3 
are ubiquitously expressed in all tissues examined. Furthermore, SGK1 is to a 
greater extent regulated by insulin-like growth factor 1 (IGF-1) whereas 
activation of SGK2 and SGK3 by H2O2 are only partially inhibited by inhibitors of 
phosphatidylinositide 3-kinase (PI3 -kinase) (Kobayashi et al., 1999a). 
SGK1 expression is regulated by aldosterone (Brennan and Fuller, 2000; Chen 
et al., 1999; Cowling and Birnboim, 2000; Náray-Fejes-Tóth et al., 1999; 
Shigaev et al., 2000), transforming growth factor beta (Waldegger et al., 1999) 
and a wide variaty of additional factors (Lang and Cohen, 2001). The activation 
of SGK1, SGK2 and SGK3 is mediated through PI3-kinase and 3-
phosphoinositide-dependent protein kinase 1 (PDK1) and PDK2 (Kobayashi 
and Cohen, 1999b; Park et al., 1999). SGK1 is involved in many physiological 
and pathological processes such as membrane transport (Wagner et al., 2001; 
Introduction 
   
23 
Wang et al., 2001; Gamper et al., 2002a, b), cell growth and survival (Xu et al., 
2001), fibrosis (Wärntges et al., 2002), chronic inflammation (Fillon et al., 2002) 
and probably hypertension (Busjahn et al., 2002). In addition, SGK has been 
shown to facilitate memory consolidation of spatial learning in rat (Tsai et al., 
2002). 
Protein kinase B was firstly discovered as a kinase with a catalytic domain 
homolog to PKA and PKC (Jones et al., 1991; Coffer and Woodget, 1991). In 
contrast to SGK, PKB has a pleckstrin homology (PH) domain. SGK1 is 
phosphorylated at Thr-256 and Ser-422 by PDK1/2 (Kobayashi and Cohen, 
1999b), PKB must be phosphorylated at two residues, Thr -308 and Ser-473 
(Alessi et al., 1996) to be active. Phosphorylation of Thr-308 is mediated by 
PDK1, whereas the mechanism of Ser-473 phosphorylation is less clear. In 
addition to PDK1, kinases potentially involved in Ser-473 phosphorylation 
include integrin-linked kinase (ILK) or an ILK associated kinase (Delcommenne 
et al., 1998; Lynch et al., 1999) and PKB itself (Toker and Newton, 2000). 
Similar to SGK, PKB is capable of phosphorylating several proteins containing 
certain sequence motifs, for instance glycogen synthase kinase 3 beta 
(GSK3b), B-RAF and the fork head transcription factor 1 (FKHRL1). PKB has 
been known to be a key mediator of the insulin signaling pathway. 
Overexpression of PKB not only leads to an increased glycogen and protein 
synthesis but also to an enhancement of glucose and amino acids uptake 
(Barthel et al., 1997; Hajduch et al., 1998). Moreover, certain changes in gene 
expression induced by insulin are stimulated by PKB (Barthel et al., 1997, 
1999). 
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1.6 The Na+/H+ exchanger regulating factor (NHERF) 
The Na+/H+ exchanger regulating factor, NHERF (also known as NHERF1 and 
ERM-binding phosphoprotein 50 (EBP50)), was firstly identified in kidney as a 
protein cofactor essential for cAMP regulation of the activity of NHE3 (Weinman 
et al., 1995). Shortly thereafter, a second member of this family was isolated 
from small intestine and renal brush border and characterized (NHERF2, also 
called NHE3 kinase A-regulated protein (E3KARP) and TKA1) as an activator of 
the platelet-derived growth factor receptor tyrosine kinase (Yun et al., 1997, 
1998). 
NHERF and NHERF2 contain two tandem protein-protein interactive PDZ 
(PSD-95/Drosophila disk large/ZO-1) domains (Weinman et al., 1995) and a 
carboxy-terminal ezrin-radixin-moesin-merlin-binding domain interacting with 
the amino-terminal domain of merlin and the ERM proteins known as ezrin-
radixin-moesin-association domain (ERMAD) (Murthy et al., 1998; Reczek and 
Bretscher, 1998). Following the demonstration that these proteins bind ezrin 
(Reczek et al., 1997), a new model was developed for regulation of target 
proteins, in which NHERF (or NHERF2), ezrin, and protein kinase form a 
multiprotein signal complex linking target protein to the actin cytoskeleton. The 
formation of this complex is proposed to facilitate the phosphorylation and 
regulation of target protein (Fig. 10). 
NHERF interacts, via its PDZ domains, with a variety of membrane receptors 
such as b2-adrenergic receptor (b2-AR), platelet-derived growth factor receptor 
(PDGFR), the P2Y1 purinergic receptor (Hall et al., 1998a, b), as well as with 
ion transport protins such as cystic fibrosis transmembrane regulator (CFTR) 
(Hall et al., 1998b), the G protein-coupled receptor kinase (GRK6A) (Hall et al., 
1999), the b1-subunit of the H+-ATPase (Breton et al., 2000), c-yes tyrosine 
kinase-associated protein (YAP65) (Mohler et al., 1999) and NHE3 (Weinman 
et al., 1998). 
A previous study has shown, that the potassium channel, Kv1.3, which contains 
PDZ binding motifs at the carboxy-terminal was targeted apically in polarized 
cells, whereas its splice variant devoid of PDZ motifs was localized at the 
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basolateral membrane (Ponce et al., 1997). NHERF and NHERF2 are 
predominantly found in the apical membrane indicating their involvement in 
directing target proteins to the apical membrane. Moreover, ezrin, an anchoring 
protein interacting with NHERF, is exclusively associated with apical 
membranes (Shenolikar et al., 1988). However, NHERF can also be found 
basolaterally thus permitting NHERF to target certain proteins to the basolateral 
membrane such as the Na+-HCO3- cotransporter (Bernardo et al., 1999). 
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Fig. 10. NHERF, a membrane-cytoskeletal adapter. The interaction between 
NHERF and target protein oocurs via the second PDZ domain (PDZ2) 
of NHERF and an internal region (PDZ binding motifs) located within 
the cytoplasmic domain of target protein. The second PDZ domain 
(PDZ2) of NHERF also binds SGK1. This is probably achieved by 
dimerization of NHERF. A homodimer of NHERF should be able to 
bind target protein on one end and SGK1 on the other end rendering 
phosphorylation and stabilization of target protein by mediating 
interaction with actin cytoskeleton via ezrin. 
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1.7 The ubiquitin protein ligase Nedd4 
Nedd4 (neuronal precursor cell-expressed, developmentally down-regulated 4) 
was identified originally as a developmentally regulated mouse gene highly 
expressed in early embryonic central nervous system (Kumar et al., 1992). 
Further analysis revealed that the expression of Nedd4 is not restricted to the 
embryonic central nervous system and that it is expressed at varying levels in 
different tissues including lung, kidney, and colon (Staub et al., 1996, 1997; 
Kumar et al., 1997). 
At the time that Nedd4 was first cloned in 1992, the only identifiable structure in 
the protein was a Ca2+/lipid-binding (CaLB) domain (C2 domain) and three to 
four repeats of approximately 40 amino acids. These repeats are now known as 
WW domains (Sudol, 1996). In 1993, the COOH-terminal region of Nedd4 was 
discovered to be similar to human papilloma virus (HPV) oncoprotein E6-
associated protein (E6-AP). E6-AP is a ubiquitin-protein ligase involved in the 
E6-mediated ubiquitination of p53 (Scheffner et al., 1993, 1995). 
The Ca2+/lipid-binding (CaLB) domain (C2 domain) is located towards the 
amino-terminus of Nedd4. The C2 domain was first identified in protein kinase C 
and is responsible for Ca2+-dependent binding of membrane phospholipids 
(Knopf et al., 1986). The function of the C2 domain in the Nedd4 protein is not 
well understood, but it might mediate the redistribution of Nedd4 from the 
cytosol to the plasma membrane in response to fluctuations in intracellular Ca2+ 
concentration (Plant et al., 1997). 
The WW domains are located between the C2 and ubiquitin-protein ligase 
domains in the middle of the Nedd4 protein. WW domains (also known as WWP 
or rsp5 domains) derive their name from the presence of two highly conserved 
tryptophan residues and a conserved proline residue in a sequence of ~35 
amino acids (Sudol, 1996). Functionally, WW domains have been proposed to 
operate in a manner similar to the SH3 domains in that they bind polyproline 
ligands (Sudol, 1996). 
The ubiquitin-protein ligase domain is situated at the COOH-termini of the 
Nedd4 protein. It is a large domain (approximately 350 residues) and was first 
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characterized in the human ubiquitin-protein ligase E6-AP, and hence is often 
referred to as the HECT (homologous to E6-AP COOH-terminus) domain 
(Scheffner et al., 1993, 1995). 
The presence of these three domains in Nedd4 suggested that Nedd4 could be 
involved in Ca2+-mediated ubiquitination of membrane protein(s). Recently, a 
number of proteins have been discovered that share the same modular 
structure as Nedd4 and appear to be part of a family of ubiquitin-protein ligases. 
Some of these proteins have been implicated in a variety of cellular functions. 
The characteristic feature of the Nedd4 family of proteins is the organization of 
the C2, WW and ubiquitin-protein ligase domains. Two closely related Nedd4 
isoforms (or paralogues) exist: Nedd4-1 (also named Nedd4, KIAA0093, or 
RPF1) and Nedd4-2 (also known as KIAA0439, LdI-1, Nedd4La, Nedd18, or 
Nedd4-L) (Kamynina et al., 2001). 
Nedd4-1 is composed of one C2 domain, a HECT domain, and three to four  
WW domains. The rat and mouse species contain three WW domains, whereas 
in humans there are four WW domains. The difference in the number of WW 
domains may be due to alternative splicing, as there is evidence for multiple 
transcripts in human Nedd4-1 (Kamynina et al., 2001). 
Nedd4-2 contains four WW domains and a HECT domain (Fig. 11). Only human 
and Xenopus laevis Nedd4-2 comprise a C2 domain, whereas such a domain 
appears to be lacking in mouse Nedd4-2. Again, there is evidence for 
alternative splicing of this isoform as well (Chen et al., 2001; Kamynina et al., 
2001), and there may be isoforms that contain, and others that do not contain, a 
C2 domain. 
It has been proposed that the WW domains of Nedd4 bind to the proline-rich 
motifs (XPPXY) present in the carboxy-termini of the three subunits of ENaC 
(Staub et al., 1996) and that binding to the channel allows subsequent 
ubiquitination of several lysine residues in the amino-termini of the a- and g-
subunits but not in the b subunit. Although a- and g-subunits are ubiquitinated 
by Nedd4, only ubiquitination of a-subunit is functionally important (Staub et al., 
1997). By analogy to certain membrane proteins with rapid turnover, 
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ubiquitination of ENaC could serve as a signal for retrieval of channels from the 
plasma membrane and their subsequent degradation in lysosomes. In fact, 
coinjection of Nedd4 and ENaC in Xenopus oocytes decreases the amiloride-
sensitive current of wild -type ENaC channels but not channels lacking the 
proline-rich motifs (Goulet et al., 1998; Abriel et al., 1999). 
If Nedd4 were to decrease the number of channels at the cell surface, it would 
be an attractive candidate as a mediator of inhibitory processes such as the 
effects of increasing intracellular Na+. The rate of Na+ entry across the apical 
membrane is regulated to match the basolateral extrusion rate and thereby to 
maintain cell volume and intracellular Na+ concentration [Na+]i. In salivary 
glands, increased [Na+]i inhibits ENaC by a mechanism that involves subunits of 
the guanine nucleotide-binding Go protein (Komwatana et al., 1996). The 
intermediate steps of the pathway are not known. Dinudom et al.,1998, seeking 
evidence linking Nedd4 to this pathway, showed that the inhibitory effect of 
increasing [Na+]i in salivary cells could be abolished by blocking the activity of 
Nedd4 either with anti-Nedd4 antibodies or by injecting fusion proteins 
containing WW domains (Dinudom et al., 1998; Harvey et al., 1999). Similar 
results were obtained in oocytes where increasing concentrations of [Na+]i 
produced a reduction of the amiloride-sensitive current in oocytes expressing 
wild-type ENaC but not in oocytes expressing the carboxy-terminal truncated 
channels (Kellenberger et al., 1998). 
Recently, Lu et al., 1999, showed that the WW domains of Nedd4 bind with high 
affinity to peptides containing serines or threonines, but only when the peptides 
are phosphorylated at the serine or threonine residues (Lu et al., 1999). The 
amino acid sequences of the peptides recognized by the WW domains of 
Nedd4 were different from the previously reported proline-rich peptides, which 
also can interact with Nedd4 in vitro but with low affinity. Some of the known 
substrates for Nedd4 are proteins such as uracil permease and Cdc25C that do 
not contain the typical proline-rich motifs but have serine and threonine residues 
that undergo phosphorylation. The findings of Lu are consistent with Nedd4 
mediating the ubiquitination of proteins by binding to sequences containing 
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phosphoserine or phosphothreonine different from the bona fide proline-rich 
motifs, and thus raise questions about ENaC being a substrate for Nedd4. 
Even if Nedd4 turns out not to bind ENaC, all the currently available data can 
still be explained because the proline-rich domains of ENaC also contain 
endocytic signals for removal of channels from the plasma membrane 
(Shimkets et al., 1997). Therefore, deletions or disruptions of these sequences 
would retain channels in the plasma membrane explaining all the mutagenesis 
performed in vitro and also the phenotype of the mutations found in patients 
with hypertension. 
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Fig. 11. Domain organization of Nedd4-2 with the consensus 
phosphorylation sites of SGK1, depicting the C2 domain, four 
WW domains and the ubiquitin protein ligase HECT domain (right 
panel). The binding of Nedd4-2 to targets proteins (proline-rich 
proteins) is shown, resulting in ubiquitination, internalization, and 
subsequent degradation of these proteins (left panel). 
Abbreviations are: C2, Ca2+-dependent lipid binding; WW domains, 
named after a pair of conserved tryptophans, are highly compact 
(35-45 residues) modular domains and serve protein-protein 
interaction; HECT, a domain homologous to the E6-AP-COOH-
terminal domain is the catalytic portion of this protein. 
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1.8 Xenopus laevis oocytes and electrophysiological recording 
One of the first and still most widely used assay system for quantifying an 
authentic protein biosynthetic process is the fully grown oocyte of the South 
African clawed frog, Xenopus laevis. The value of Xenopus laevis first became 
apparent in 1971, when Gurdon and co-workers discovered that the oocyte 
constitutes an efficient system for translating foreign messenger RNA (Gurdon 
et al., 1971). 
The Xenopus oocyte is a cell specialized for the production and storage of 
proteins for later use during embryogenesis and developmentally divided into 6 
stages (Dumont, 1972). In addition, the complex architecture of the frog oocyte 
includes the subcellular systems involved in the export and import of proteins. 
Therefore, the mRNA-microinjected oocyte is an appropriate system in which to 
study the synthesis of specific polypeptides, as well as the storage of particular 
proteins in various subcellular organelles and the export of others into the 
extracellular space. Moreover, the subcellular compartmentalization, as well as 
the structure and biochemical, physiological, and biological properties of the 
synthesized protein, may be examined from exogenous proteins in the injected 
oocyte (reviewed in Wagner et al., 2000). 
For experimental studies oocytes of stages V-VI are used with a diameter of 
some 1.3 mm allowing easy preparation. The developmental stages V-VI are 
characterized by the occurence of 2 poles i.e. the vegetable (light) and the 
animal (dark) poles. While the nucleus resides in the animal pole (Nieuwkoop, 
1977), more mRNA is present in the vegetable pole (Capco and Jeffery, 1982). 
The main ion conductance in Xenopus oocytes is a Ca2+-dependent Cl- 
conductance governing the resting membrane potential close to the Cl- reversal 
potential of -40 mV, (Dascal, 1987). 
The primary advantage of using Xenopus oocytes for the expression of 
transporters is the ability to perform detailed electrophysiological recording 
using an in vivo system. In the simplest arrangement, the membrane is 
penetrated with a single microelectrode and the membrane potential is 
measured. The oocyte  can easily be penetrated with two microelectrodes. This 
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arrangement allows the use of one of the two classical methods: current clamp 
or voltage clamp. Most electrophysiological studies on oocytes were performed 
using the two-electrode voltage-clamp. The large size of the oocytes also 
permits extracellular recording of currents flowing through the cell membrane at 
various locations using a vibrating probe. The patch clamp method has been 
successfully applied in devitellinized oocytes for the study of single channels 
(Hamill et al., 1981). 
Whole-cell voltage clamping of oocytes involves two electrodes inserted into the 
oocyte. The large size of the oocyte (about 1 mm in diameter and 0.5 to 1 µl in 
volume for stage V-VI oocytes) make this feasible, and is both the major 
advantage and disadvantage of the system. The advantage is that it is possible 
to insert multiple electrodes and injection needles into the same oocyte. 
Therefore, modulators of channel function can be injected inside the cell while 
recording, so that a rapid and direct response to an intracellular signal can be 
observed. The disadvantage is that the large size results in an extremely large 
membrane capacitance (about 150-200 nF), which causes a slow clamp setting 
time following voltage shifts. This makes it difficult to obtain any data during the  
first 1 to 2 msec of a hyper- or depolarization, the time during which rapidly 
activating voltage sensitive channels such as the cardiac sodium channel open. 
The large capacitance is not a serious problem in examining slow responses or 
ligand-gated responses in the absence of voltage shifts (Stuhmer, 1992). 
Despite their advantages, several precautions should be taken into 
consideration. First, the expression of endogenous carriers may interfere with 
the exogenously expressed proteins in various ways. For instance, it has been 
observed that injection of heterologous membrane proteins at high levels can 
induce endogenous channe ls (Tzounopoulos et al., 1995). Second, due to the 
fact that Xenopus laevis is a poikilothermic animal, its oocytes are best kept at 
lower temperature and most experiments are carried out at room temperature. 
Hence, temperature sensitive processes i.e. protein trafficking or kinetics may 
be altered (Wagner et al., 2000). 
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Finally, since Xenopus oocytes may have different signaling pathways, 
precaution should be taken when studying the regulation of expressed proteins. 
It has been revealed that the PTH receptor regulates the internalization of NaPi, 
mediated by the PKA and PKC pathway. However, in NaPi-3 expressing 
Xenopus oocytes PKC-mediated PTH regulation can not be observed (Wagner 
et al., 1996). Instead, coupling to the PKA pathway leads to the alteration of 
PKA-regulated ion channels (Waldegger et al., 1996). Exposing the Xenopus 
oocytes to the regulators of intracellular signaling such as PKC activator phorbol 
esters may unspecifically lead to internalization of the plasma membrane and 
the expressed proteins (Vasilets and Schwarz,  1992; Loo et al., 1996). 
In summary, the Xenopus oocyte system has the advantage that channels, 
receptors and transporters can rapidly be expressed and analyzed both 
biochemically and electrophysiologically in an in vivo situation. The system can 
be used quite effectively as an assay for the functional cloning of channels that 
have only been identified by their electrophysiological properties. Once cDNA 
clones have been isolated, oocytes are an excellent system for correlating 
structure with function using a combination of molecular biological and 
electrophysiological techniques. 
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1.9 AIMS OF THE PRESENT STUDY 
The motivation of this study was to resolve the role of Serum and Glucocorticoid 
Inducible Kinase isoforms, ubiquitin protein ligase Nedd4-2 and NHE3 
regulating factor 2 in the regulation of renal tubular transport. To this end the 
major channels mediating transport of potassium, calcium and chloride which 
are expressed in the renal tubules have been investigated. It included: 
(1) ROMK1 channel: 
· Identification of a mutual interaction of SGK1 and NHERF2 in the 
regulation of ROMK1 channel acivity. 
· Exploration whether alterations of the charge at phosphorylation site of 
SGK1 on the ROMK1 indeed modify the pH sensitivity of ROMK1. 
· Definition of the molecular requirements for the interaction of ROMK1 
with SGK1/NHERF2. 
(2) ECaC1 (TRPV5) channel: 
· Investigation of the role of SGK isoforms, protein kinase B and NHERF2 
in the regulation of ECaC1 (TRPV5) activity. 
· Definition of the molecular requirements for the interaction of ECaC1 
(TRPV5) with SGK1/NHERF2. 
(3) CIC-Ka/barttin channels: 
· Verification of general implications for the regulation of CIC-Ka/barttin 
chloride channels by the ubiquitin protein ligase Nedd4-2 and the SGK 
isoforms SGK1, SGK2 and SGK3. 
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2.1 Equipment and materials 
 
2.1.1 Laboratory equipment 
 
Acquisition software ADInstruments, Castle Hill, Australia 
Autoclave    Technoklav 50, Tecnomara, Fernwald 
Balance Mettler AE 163, Mettle r Waagen, Gießen 
Digitization board ITC16, HEKA electronics, Lamprecht 
Digital-pH-Meter 646 Knick, Freiburg 
Electrode puller DMZ-Universal Puller, Zeitz-Instrumente, 
Augsburg 
Gel electrophoresis Horizon 58, Life Technologies, Gaithersburg 
MD, USA; power supply EPS 600, Pharmacia 
Biotech, Uppsala, Sweden 
Incubator    WTB Binder, Tuttlingen 
Incubator Type B 5070   Heraeus, Hanau 
Liquid scintillator   Wallac, Freiburg 
Microcentrifuge MC13  Amicon, Austin, Texas, USA 
Microcentrifuge Micro12-24 Bachofer, Reutlingen 
Microinjector World Precision Instruments, Sarasota, 
Florida, USA 
Minifuge RF    Heraeus, Hanau 
Oscilloscope    HM 1007, Hameg, Frankfurt 
Precision forceps (size 3 & 5) Dumont, Basel, Switzerland 
Pump     WISA, Wuppertal 
PCR-Mastercycle gradient  Eppendorf, Hamburg 
Photometer    Eppendorf, Hamburg 
Pipettes Pipetman P2/P20/P200/P1000, Gilson Medical 
Electronics, Villiers-le-Bel, France 
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Refrigerator UF 85-300S  Colora Messtechnik, Lorch 
Shakers MS1 IKA Works Inc., Wilmington NC, USA, 
and Thermomixer 5436 Eppendorf, Hamburg 
Speed Vac (Vacum conc.)  Bachofer, Reutlingen 
Temperature-controlled bath GFL 1003, Gesellschaft für Labortechnik mbH, 
Burgwedel 
TEVC Ampliffier Axon Instruments, Inc., USA 
Ultrasonic bath   Transsonic T420, Elma, Singen 
UV-Spectrometer    GeneQuant Amersham-Pharmacia, Freiburg 
Vortex Genie 2    Bender & Hobein AG, Zürich, Schwitzerland 
Water Filter Seralpur UP 50 Seral, Ransbach-Baumbach 
 
2.1.2 Materials 
 
Embedding polymer Technovit 7100, Heraeus Kulzer, Wehrheim 
Filter tips SafeSeal Tips, Biozym Diagnostic, Oldendorf 
Glass slides Superior, sealed with Entellan, E. Merck, 
Darmstadt 
Microloaders    Eppendorf, Hamburg 
Petri dishes (sterile)  Greiner, Frickenhausen 
X-ray films Biomax MR, Eastman Kodak Company, 
Rochester NY, USA 
 
2.1.3 Chemicals and reagents 
 
Agar Agar    Roth, Karlsruhe 
Agarose electrophoresis grade, Life Technologies, 
Paisley, Scotland 
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Antibiotics I stock solution (10.000 U Ampicillin and 10 mg 
streptomycin per ml), Sigma, St. Louis, 
Missouri, USA 
Antibiotics II stock solution (50 mg Gentamycin per ml), 
Sigma, St. Louis, Missouri, USA 
Bovine serum albumin Sigma-Aldrich, Deisenhofen 
Bromphenol blue    Sigma-Aldrich Chemie, Steinheim 
Cap-Analog m7G(5’)ppp(5’)G Roche, Mannheim 
Carbontetrachloride  Fluka Chemicals, Deisenhofen 
Chemoluminescence ECL kit Amersham, Freiburg 
Collagenase D Roche, Mannheim 
cRNA synthesis and DNAse I mMessage-mMachine kit, Ambion, Austin, 
USA 
Cu-phenanthroline    Sigma-Aldrich Chemie, Steinheim 
Developer and replenisher Biomax MR, Eastman Kodak Company, 
Rochester NY, USA 
Diethylpyrocarbonat (DEPC) Sigma-Aldrich, Deisenhofen 
Dimethylsulfoxid (DMSO)  Sigma-Aldrich, Deisenhofen 
DNA-Ladder, 1 kb and 100bp Life Technologies, Eggenstein 
DNA sequencing kit DNA Sequencing Kit, Amersham, Cleveland, 
USA 
DNAase (RNAase free)  Roche, Mannheim 
dNTPs, 100 mM   Life Technologies, Eggenstein 
DTT, DTNB    Sigma, St. Louis, Missouri, USA 
EDTA     Sigma-Aldrich Chemie, Steinheim 
EGTA     Sigma-Aldrich Chemie, Steinheim 
Ethidium bromide   Sigma-Aldrich Chemie, Steinheim 
Ficoll Sigma-Aldrich Chemie, Steinheim 
Fixer and replenisher Biomax MR, Eastman Kodak Company, 
Rochester NY, USA 
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FmocCl    Sigma, St. Louis, Missouri, USA 
Formamid    Roth, Karlsruhe 
Glutathione-sepharose 4B  Pierce Biotechnology Inc., Rockford, lL; USA 
beads 
Glycerol-gelatin   Sigma-Aldrich, Deisenhofen 
GSH     Sigma, St. Louis, Missouri, USA 
H+-cocktail proton ionophore II-cocktail A, Fluka 
Chemicals, Deisenhofen 
ImmunoPure immobilized  Pierce Biotechnology Inc., Rockford, lL; USA 
Streptavidin beads 
Isopropanol    Sigma-Aldrich Chemie, Steinheim 
LB medium Luria Broth base, Gibco BRL, Life 
Technologies, Paisley, Scotland 
[35S]methionine NEN life science products Inc.,Boston, MA; 
USA 
Mercaptoethanol   Sigma-Aldrich Chemie, Steinheim 
Methoxyverapamil   Sigma-Aldrich Chemie, Steinheim 
Normal Goat serum   Sigma, St. Louis, Missouri, USA 
Paraformaldehyde   Sigma-Aldrich Chemie, Steinheim 
PCR buffer Gibco BRL, Life Technologies, Karlsruhe 
pGEX-4T Amersham Pharmacia Biotech AB, Uppsala, 
Sweden 
pGEX6p-2 Amersham Pharmacia Biotech AB, Uppsala, 
Sweden 
Plasmid preparation kit  Midi Prep Kit, Quiagen, Hilden 
Poly-Acrylamide   Applichem, Darmstadt 
Primary antibodies rat monoclonal anti-HA, Roche, Mannheim, 
mouse monoclonal anti-V5, Invitrogen, 
Karlsruhe 
Primary rabbit anti-ROMK1 Chemicon, Temecula, USA 
antibody 
QIAfilter Plasmid Midi Kit  Qiagen, Hilden 
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QuickChangeTM Site-directed Stratagene, Heidelberg 
Mutagenesis kit 
Restriction enzymes  Boehringer, Mannheim 
RNAase inhibitor   Promega, Mannheim 
RNA ladder 0.24-9.5 kb RNA Ladder, Life Technologies, 
Karlsruhe 
Scintillation fluid Ultima Gold, Packard, Groningen, the 
Netherlands 
SDS Roth, Karlsruhe 
Secondary antibodies Cy-2- or Cy-3-coupled antibodies, Amersham 
Pharmacia Biotech, Freiburg 
Secondry Alexa 488 goat   Molecular Probes, Leiden, The Netherlands 
anti-rabbit antibody 
Sulfo-NHS-LC-Biotin  Pierce Biotechnology Inc., Rockford, lL; USA 
Taq polymerase Gibco BRL, Life Technologies, Karlsruhe 
T7 (or Sp6) RNA Polymerase Roche, Mannheim 
Tributylchlorosilane   Fluka Chemicals, Deisenhofen 
Tris-HCI Sigma-Aldrich Chemie, Steinheim 
Tween 20 Roth, Karlsruhe 
X-ray films Biomax MR, Eastman Kodak Company, 
Rochester NY, USA 
5’-Cy5 labelled primers Gibco BRL, Life Technologies, Karlsruhe 
45Ca2+     ICN Biomedicals, GmbH, Eschwege 
 
Other chemicals are of high chemical grade and purchased from Sigma 
(Deisenhofen), Fluka (Deisenhofen) or Roche (Mannheim). 
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2.1.4 Solutions, medium and buffer 
 
Table 1: Solutions related to E. coli Bacteria 
 
 LB-Medium LB-
Selection- 
Medium 
LB-Agar SOB-
Medium 
SOC-
Medium 
Ampicillin 
(µg/ml) 
- 100 - - - 
Bactoagar % 
(w/v) 
- - 1.5 - - 
Bactotrypton % 
(w/v) 
1 1 1 2 2 
Glucose 
(mmol/l) 
- - - - 20 
Yeast extract % 
(w/v) 
0.5 0.5 0.5 0.5 0.5 
KCl (mmol/l) - - - 2.5 2.5 
MgCl2 (mmol/l) - - - 10 10 
NaCl % (w/v) 1 1 1 0.05 0.05 
pH 7.4 7.4 7.4 7.0 7.0 
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Table 2: Solutions used for enzymatic defolliculation and storage of 
Xenopus oocytes 
 
 ND96 ND96 Storage 
Solution 
OR-2 (Oocytes-
Ringer) 
NaCl (mmol/l) 96 96 82.5 
KCl (mmol/l) 2 2 2 
CaCl2 (mmol/l) 1.8 1.8 - 
MgCl2 (mmol/l) 1 1 1 
Tris-HEPES (mmol/l) 5 5 5 
Na-Pyruvate (mmol/l) - 2.5 - 
Theophylline (mmol/l) - 0.5 - 
Gentamycin (µg/ml) - 50 - 
pH 7.4 7.4 7.4 
 
Table 3: Solutions used for ROMK1 and CIC-Ka/barttin measurements 
 
 ND96 
NaCl (mmol/l) 96 
KCl (mmol/l) 2 
CaCl2 (mmol/l) 1.8 
MgCl2 (mmol/l) 1 
Tris-HEPES (mmol/l) 5 
pH 7.4 
 
The final solutions were titrated to the pH indicated using HCl or NaOH. The 
flow rate of the superfusion was 20 ml/min and a complete exchange of the bath 
solution was reached within about 10 s. 
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Table 4: Solutions used for ECaC1 measurements 
 
 Storage 
solution 
Bath 
solution 
Wash 
solution 
Uptake 
solution 
Stop 
solution 
NaCl (mmol/l) 88 96 96 96 96 
KCl (mmol/l) 1 2 2 2 - 
CaCl2 (mmol/l) 0.4 - - 0.1 0.5 
MgCl2 (mmol/l) - 1 1 1 1 
MgSO4 (mmol/l) 0.8 - - - - 
BaCl2 (mmol/l) - 1 1 1 - 
45Ca2+ (µCi/ml) - - - 7 - 
Ca(NO3)2 (mmol/l) 0.3 - - - - 
LaCl3 (mmol/l) - - - - 1.5 
NaHCO3 (mmol/l) 2.4 - - - - 
EGTA (mmol/l) - 1 1 - - 
HEPES (mmol/l) 5 5 5 5 5 
Gentamycin 
(µg/ml) 
25 - - - - 
Methoxyverapamil 
(µmol/l) 
- 10 10 10 - 
pH 7.4 7.4 7.4 7.4 7.4 
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Table 5: Buffers used for Molecular Biology 
 
 PBS-
Buffer 
TAE-
Buffer 
TBE-
Buffer 
TE-4-Buffer Ooytes lysis 
Buffer 
Boric acid 
(mmol/l) 
- - 8.9 - - 
EDTA (mmol/l) - 1 1 - 0.5 
EGTA (mmol/l) - - - - 0.5 
Acetic acid 
(mmol/l) 
- 20 - - - 
KH2PO4 
(mmol/l) 
10 - - - - 
NaCl % (w/v) 0.9 - - - 0.6 
Na2-EDTA 
(mmol/l) 
- - 0.1 - - 
Na2PO4 (mmol/l) 10 - - - - 
Tris-HCl 
(mmol/l) 
- 40 8.9 10 50 
Triton X-100% - - - - 1 
Aprotinine µg/ml - - - - 25 
Leupeptin µg/ml - - - - 25 
pH 7.4 8 9 8 8 
 
· PBS-Buffer: phosphate-buffered saline. 
· TAE-Buffer: Tris-acetate/EDTA electrophoresis buffer. 
· TBE-Buffer: Tris-borate/EDTA electrophoresis buffer. 
· TE-4-Buffer: Tris-EDTA. 
· Aprotinine and Leupeptin: protease inhibitors only added in oocytes 
lysis buffer. 
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Table 6: Buffers used for DNA Gel Electrophoresis 
 
 Agarose-Simple 
Buffer 
6 x Sample 
Buffer 
4 x SDS-PAGE 
Loading Buffer 
2-Mercaptoethanol (ml) - - 0.4 
Bromphenol blue % 
(w/v) 
0.01 0.25 0.4 ml 1% (w/v) 
Ficoll 400% (w/v) 20 - - 
Glycerol % (v/v) - 30 40 
H2Odest. (ml) - - 1.9 
SDS (ml) - - 1.6 ml 10% 
TBE 1 x - - 
Tris-HCl (ml) - - 1 ml 0,5 M 
Xylenxyanol % (w/v) - 0.25 - 
pH - - 6.8 
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2.2 Heterologous expression in Xenopus oocytes 
 
2.2.1 In vitro cRNA transcription 
As illustrated in Fig. 12, in vitro cRNA transcription involves 2 consecutive steps 
i.e. linearisation of the plasmid DNA containing the inserted cDNA of interest by 
the corresponding restriction enzyme and the synthesis of RNA. 
a. The inserted DNA should be cut at the 3’ end yielding a 5’ protruding or a 
blunt end by restriction enzyme. Plasmid DNA (10 µg) was incubated with 20 
U restriction enzyme and an 10x buffer (5 µl) in a final volume of 50 µl at 
37°C for 2 h or overnight. 
b. To ascertain the linearization process, a 5 µl aliquot was taken out and 
analysed on a 1% agarose. 
c. 1 volume isopropanol (50 µl) and 1/10 volume 3 M sodium acetate (5 µl) pH 
5.2 was then added and incubated at room temperature for 10 min to 
precipitate the DNA. 
d. The precipitated DNA was recovered by centrifugation at 17,000 rpm for 15 
min at 4°C. The DNA pellet was washed by adding 100 µl of cold 70% 
ethanol to the pellet followed by centrifugation at 17,000 rpm for 5 min at 
4°C. This washing stage was repeated. The DNA pellet was air dried and 
then resuspended in 10 µl of DNase free H2O. The concentration of DNA was 
determined spectrophotometrically by measuring the absorbance at 260 nm. 
e.  1 µg of linearised DNA was added to 1 µl rNTPS (20 nM), 2.5 µl Cap 
analogue (to prevent the degradation of the 5’ end of the synthesized RNA), 
1 µl RNAase inhibitor (to protect the RNA from degradation by RNAase) and 
2.4 µl 10 x transcription buffer(s). 
f. After mixing, 1 µl of T7 polymerase was added and then incubated at 37°C 
for 1 h. 
g. 1 µl DNase was added and the mixture was subsequently shaken for 15 min 
at 37°C. 
h. After addition of 100 µl DEPC-water and 125 µl phenolchloroform, the 
mixture was centrifuged at 13,000 rpm for 2 min. 
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i. The upper part, inorganic phase, was then removed and placed into a new 
Eppendorf tube. 
j. The inorganic phase was frozen at -70°C for a minimum of 15 min after 
addition of 12.5 µl of 3 M sodium acetate at pH 5.2 and 375 µl 100% ethanol. 
k. After centrifugation at 17000 rpm for 15 min at 4°C, the supernatant was 
removed and the pellet was washed 2 times with 200 µl of 70% ethanol. 
l. The washed pellet was dried at room temperature and reconstituted in 25 µl 
of DEPC water. 
m. The RNA was quantified by measuring the absorbance at 260 nm. 
To increase the translation of the cloned cRNA in Xenopus oocytes, the plasmid 
vectors also contained 5’ and 3’ untranslated regions of cDNA such as the one 
coding for b-globin. 
Transcription
Vector
SP6 T7
prepare plasmid 
with an appropriate
restriction enzyme
to linearize DNA
add RNA synthesis reaction
components (appropriate
RNA polymerase and NTPs)
and incubate
remove DNA template with
RQ1 DNase
run-off transcripts
purified RNA transcripts
 
 
Fig. 12. Steps of in vitro cRNA transcription (adapted from Swanson and 
Folander, 1992). The common RNA polymerases used for in vitro 
transcription are SP6, T7 and T3 polymerases, named for the 
bacteriophages from which they were isolated or cloned. These RNA 
phage polymerases are DNA template-dependent and have distinct, 
highly specific promoter sequence requirements. Depending on the 
orientation of the DNA sequence relative to the promoter, the template 
may be designed to generate a sense or antisense strand RNA. 
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Table 7: List of plasmids used with additional informations for in vitro 
transcription 
 
 Plasmid 
Vector 
Resistance Restriction 
Enzyme 
Polymerase Provided by 
ROMK1 pSport Ampicillin Not I T7 Cecilia 
Canessa 
S44DROMK1 pSport Ampicillin Not I T7 
S44AROMK1 pSport Ampicillin Not I T7 
ROMKHA PBF Carbenicillin Mlu I Sp6 
ROMKD4 pSport Ampicillin Not I T7 
Monica 
Palmada 
ECaC1 (TRPV5) pSport Ampicillin Not I T7 Rene 
Bindels 
CIC-Ka PTLN Ampicillin Mlu I Sp6 
Barttin POG Ampicillin Ksp l T7 
Siegfried 
Waldegger 
Y98ABarttin POG Ampicillin Ksp l T7 Monica 
Palmada 
Nedd4-2 PSPeasy 
SB 
Ampicillin Clal Sp6 Olivier 
Straub 
SGK1 pOG Ampicillin Not I T7 Siegfried 
Waldegger 
SGK2-3 pGEMHJ Ampicillin StuI/NotI T7 Yuxi Feng 
S422DSGK1 pGHJ Ampicillin SalI/StuI T7 
K127NSGK1 pGHJ Ampicillin Stu I T7 
T308D,S473DPKB pGHJ Ampicillin Sal I T7 
 
 
Philip Cohen 
NHERF2 PET30a Kanamycin Sal I T7 
NHERF2DP1 PET30a Kanamycin Xho I T7 
NHERF2DP2 PET30a Kanamycin Sal I T7 
 
Chris Yun 
 
The present table indicates the restriction enzymes and RNA polymerases 
needed for linearization and transcription for every plasmid used in this work. 
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 2.2.2 Preparation of oocytes 
An adult female Xenopus laevis frog was submersed in one liter of 3-
aminobenzoic acid ethyl ester (0.1%) for about 15-30 min (Fig. 13A). After the 
frog was fully anesthetized it was placed on ice for surgery. A small abdominal 
incision (1 cm) was carried out and a segment of ovary was removed (Fig. 13B, 
C). Subsequently the wound was closed with a reabsorbable suture (Fig. 13D). 
The frog was then kept wet and warm by placing it in a cavity filled by a small 
amount of warm water to avoid drowning and hypothermia. 
The ovarial sacs were manually separated into groups of 10-20 oocytes, put 
into a 15 ml tube and then enzymatically defolliculated by treatment with an OR-
2 (Oocytes-Ringer) solution containing 1-2 mg/ml collagenase A for 2-2.5 h at 
room temperature (Fig. 13E) with gentle agitation. 
Defolliculation of the oocytes was stopped by washing several times with ND96. 
This step also removes all detritus permitting oocyte sorting. Oocytes were then 
sorted using a self-made apparatus (Fig. 13F). Only large oocytes (stage V or 
VI) were selected and stored overnight in a ND96 storage solution at 16°C. 
 
 2.2.3 cRNA injection 
After storing overnight, oocytes were injected using glass microcapillaries (filled 
with the required cRNA) mounted in a micromanipulator-controlled microinjector 
(Fig. 13G). Precaution should be taken that cRNA was not contaminated with 
RNAases and that the injection capillary was not clogged with small particles. 
To avoid those problems several procedures were carried out such as using 
only steri le pipettes, gloves and DEPC treated water for dilution of cRNA. 
Glass capillaries were pulled using a normal puller. The tip was manually 
broken under the microscope (diameter of about 10-20 µm), backfilled with 
paraffin oil to seal the pipette from air and loaded with cRNA by suction (usually 
1-2 µl). 
Ooytes were then placed into a 35 mm petri dish with a polypropylene mesh 
glued to the bottom to fix the oocytes and injected with a given volume of cRNA 
(usually 25 nl). 
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After injection, oocytes were kept in storage solution at 15°C. To avoid sticking 
of oocytes to the petri dish or to other oocytes, the dish was gently shaken. At 
least every two days the storage solution was exchanged and damaged oocytes 
were removed to maximise the survival of the oocytes. 
 
A B
C D
E F
G
 
 
Fig. 13. Steps of the oocytes preparation and injection. (A) The frog is 
anesthetized in 1 liter of 3-aminobenzoic acid ethyl ester (1%) in tap 
water at near room temperature. (B) The frog is placed on its back 
during operation. An incision about 1 cm long is made in the skin. (C) 
A small portion of the ovary is pulled out with forceps and removed 
with a pair of scissors. (D) The peritoneum and the muscle tissue are 
sewn up and then the skin closed off using cat gut. (E) The clump of 
oocytes is immediately transferred to a petri dish containing modified 
Barth medium with antibiotic. (F) Oocytes of stage V and VI are 
separated with a platinum wire loop. (G) For injection, the oocytes are 
aligned relative to the tip of the needle. 
Materials and Methods 
   
 
50  
2.3 Electrophysiological recording 
 
2.3.1 Two-electrode voltage-clamp 
Two-electrode voltage-clamp (TEVC) was used to measure whole cell currents 
in Xenopus laevis oocytes expressing ion transport or channels . As shown in 
Fig. 14, oocytes were impaled by two glass electrodes. One was to record 
membrane potential while the other was to deliver currents. Both were made 
from pulled glass capillaries with a thin filament which were filled with 3 mM KCl 
and subsequently inserted with an Ag/AgCl2 electrode. The bath-grounding 
electrode was made of 3% agar and 3 M KCl. 
The membrane potential electrode was connected to a feedback amplifier 
comparing the signal with the voltage clamp command. The difference of these 
signals, which was higly amplified, was applied as a current through the other 
electrode across the cell membrane and to the bath-grounding electrode. The 
whole set up was grounded and shielded with a Faraday cage (Ohlemeyer and 
Meyer, 1992). 
In two-electrode voltage-clamp experiments of ROMK1, currents were recorded 
following a step change of the holding potential from -80 mV to -20 mV. For 
electrophysiological measurements of ECaC1, currents were recorded during a 
4s linear voltage ramp from -150 mV to +50 mV or 2.5 s voltage step from -50 
mV to -110 mV. The intermediate holding potential between the voltage ramps 
was -50 mV. But, in case of CIC-Ka/barttin, currents were determined in two-
electrode voltage-clamp experiments utilizing a pulse protocol of 1 s pulses 
from -140 mV to +40 mV. The intermediate holding-voltage was -60 mV. 
Steady-state current at the end of each voltage step was taken for data 
analysis. Data were filtered at 10 Hz, and recorded with MacLab digital to 
analog converter and software for data acquisition and analysis 
(ADInstruments, Castle Hill, Australia). The flow rate of the superfusion was 20 
ml/min and a complete exchange of the bath solution was reached within about 
10 s. 
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Fig. 14. The two-electrode voltage-clamp (adapted from Baumgartner et al., 
1999). The voltage recording electrode eV monitors the membrane 
potential; this is compared with a command voltage Vc, and the 
magnified difference is applied to a current injection electrode, eI. A 
bath electrode eB serves as the  return path for the injected current. 
 
2.3.2 Recording of intracellular pH (pHi) 
Intracellular pH measurements were performed using ion-selective 
microelectrodes prepared from pulled borosilicate electrodes, which were 
silanized and filled with H+-ionophore and backfilled solution. Silanization 
changes the lipophobicity of the capillary and it was important to allow the 
ionophore to reach the tip of the electrodes (Thomas, 1978). Silanization was 
carried out by backfilling the prospective ion-selective electrode with 5% 
tributylchlorosilane in 99.9% pure carbon tetrachloride (Fig. 15A). To ensure a 
smooth coating and to remove the solvent, the electrodes were baked at 400-
450°C for 5 min (Fig. 15B). A column of H+ cocktail (proton ionophore II-cocktail 
A, Fluka Chemicals, Deisenhofen) was filled into the tip of the silanized 
electrode. The silanized electrode was then backfilled with a solution of 100 mM 
Na-citrate, pH 6.0, whereas the shank of the reference electrode was filled with 
3 M KCl (Fig. 15C). The electrodes were calibrated using solutions with pH 6.0, 
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7.0 and 8.0. Only electrodes with a linear slope > 50 mV/pH unit and stable 
calibration were used. Signals were recorded with an electrometer (WPI model 
FD223, Sarasota, FL, USA). 
On the basis of the calibration curve for the pH-sensitive electrode, the chemical 
potentials for H+ (EH+) of oocytes were calculated as the difference between the 
membrane potential measured simultaneously with a 3 M KCl microelectrode 
and the electrochemical potential of the pH-sensitive electrode (VH+). Where 
applicable, intracellular pH has been adjusted by variations of extracellular pH 
in the presence and absence of 3 mM butyrate. 
As shown in Fig. 16, oocytes were impaled by two electrodes i.e reference and 
ion-selective electrodes, respectively, which were placed on a three-
dimensional micromanipulator and connected via Ag/AgCl2 electrodes to the 
input of an ultra-high-impendance electrometer (FD 223, WPI, New Haven, 
Conn, USA). The electrical circuit was then closed via bath electrode (3 M KCl 
agarose Ag/AgCl2).Whereas the reference electrode was used to measure the 
transmembrane potential (V m), the pH electrode was employed to measure the 
proton electrochemical potential across the membrane (VH). pHi was then 
obtained by the following equation  
pHi = pHref – (VH-Vm)/S 
where pHref is the pH of the calibration solution and S is the slope of calibration 
curve of pH electrode. Only the pH electrode having at least 50 mV/ pH unit was 
used in the studies. 
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Fig. 15. Construction of ion-selective microelectrode. Ion-selective  
electrode is prepared from pulled borosilicate electrodes, which is 
backfilled with 5% tributylchlorosilane in 99.9% carbon tetrachloride 
(A). To ensure a smooth coating and to remove the solvent the 
electrode is baked at 400-450°C for 5 min (B). A column of H+ 
cocktail (proton ionophore II-cocktail A) of ~300 µm in length, is 
established at the tip of the electrode (C). The electrode is then 
backfilled with a solution of 100 mM Na-citrate, pH 6 .0. 
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Fig. 16. Set-up for recording from ion-selective microelectrodes and their 
application for xenopus oocytes (adapted from Schwarz and 
Rettinger, 2000). 
 
2.4 Site-directed mutagenesis of ROMK1 
Site directed mutagenesis and subsequent functional studies were performed to 
elucidate the structural-functional role of the mutated sequence. For that 
purpose, site directed mutagenesis was carried out using the QuickChange TM 
site-directed mutagenesis kit (Stratagene, Heidelberg). This kit is used to make 
point mutations, switch amino acids, and delete or insert single or multiple 
amino acids. 
The basic procedure utilizes a supercoiled double-stranded DNA (dsDNA) 
vector with an insert of interest and two synthetic oligonucleotide primers 
containing the desired mutation (Fig. 17). All sequences used for the design of 
the oligonucleotide primers were obtained from the PubMed database. The 
primers, each complementary to opposite strands of the vector, are extended 
during temperature cycling by PfuTurbo DNA polymerase. Incorporation of the 
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oligonucleotide primers generates a mutated plasmid. Following temperature 
cycling, the product is treated with DpnI endonuclease. This endonuclease 
(target sequence: 5’-GmATC-3’) is specific for methylated and hemimethylated 
DNA and is used to digest the parental DNA. 
The DNA isolated from almost all E. coli strains is methylated and therefore 
susceptible to DpnI digestion. In contrast, the mutation-containing synthesized 
DNA is not methylated and is not going to be digested by DpnI, remaining in a 
circular state. Since circular DNA incorporates into bacteria much easier than 
linear DNA, only the mutated DNA is going to be inserted and replicate by the 
bacteria. After isolating the plasmid DNA, the vector is resequenced to check for 
the desired mutation and  then cRNA is synthesized as depicted in Fig. 12. 
The following primers were used to generate ROMK1D4 (ROMK1 lacking the 
last 4 COOH-terminal amino acids) and ROMK1D4-HA (ROMK1 lacking the last 
4 COOH-terminal amino acids containing hemagglutinin (HA) tag): ROMK1D4, 
sense (s): 5’ GTTGATGAAACGGACTAGCAGTGGCTTTTC 3’; ROMK1D4, 
antisense (as): 5’ GAAAAGCCACTGCTAGTCCGTTTCATCAAC 3’.Thereafter 
ROMK1D4 and ROMK1D4-HA were sequenced to verify the presence of the 
desired mutation. 
The only SGK1 phosphorylation site in ROMK1, serine44, was also mutated 
into alanine (S44AROMK1) or into aspartate (S44DROMK1). The mutation of 
serine44 into alanine avoids phosphorylation of ROMK1 by SGK1. In contrast, 
mutation of serine44 into aspartate mimicks the phosphorylation state of 
ROMK1. The following primers were used to generate S44AROMK1 and 
S44DROMK1:  
(1) S44A sense (s):                                                                                        
5’ GGCAACGGGCAAGGCTGGTCGCTAAAGAAGGAAGATGTAAC 3’ 
(2) S44A antisense (as):                                                                                          
5’ GTTACATCTTCCTTCTTTAGCGACCAGCCTTGCCCGTTGCC 3’ 
(3) S44D sense (s):                                                                                                 
5’ GCAACGGGCAAGGCTGGTCGATAAAGAAGGAAGATGTAAC 3’ 
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(4) S44D antisense (as):                                           
5’ GTTACATCTTCCTTCTTTATCGACCAGCCTTGCCCGTTGC 3’.  
Thereafter both mutants were sequenced to verify the presence of the desired 
mutation. 
 
Gene in plasmid with
mutation target site
Mix Cycle
Digest
Transform
Mutagenic primers
Mutated plasmid
 
 
Fig. 17. A Schematic representation of site-directed mutagenesis using 
the QuickChange mutagenesis kit. A plasmid (green circles) 
containing the gene of interest with site targeted for mutation (closed 
circles), is extended (arrows) from complementary primers (red bold 
arcs) containing the desired mutation (x). The extension process 
continues until the site of primer annealing is reached, yielding an in 
vitro generated copy of the plasmid with staggered nicks (blue circles). 
The parent plasmid template, originally isolated from a methylation-
competent bacterial host, is methylated; the in vitro-extended copy is 
not. The addition of DpnI leads to the digestion of the parent plasmid 
leaving the nicked copy, which is repaired in the bacterium (XL 1-Blue 
E.coli) following transformation. 
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2.5 Deletion of PDZ domains in NHERF2 
The NHERF2DP1 and NHERF2DP2 constructs were prepared via PCR from a 
human NHERF2 cDNA. The NHERF2DP1 (corresponding to amino acids 149-
337 of human NHERF2) and NHERF2DP2 (corresponding to amino acids 9-
128) were inserted into the pET-30a (Novagen) vector using EcoRI and XhoI 
sites for NHERF2DP1 and EcoRI and SalI sites for NHERF2DP2. The 
sequences of the PCR products were confirmed by nucleotide sequencing. 
 
2.6 Pull-down assays 
In order to ascertain wether ECaC1 (TRPV5) and NHERF2 interact with one 
another, pull-down assays were performed. The amino- and carboxy-tails of 
mouse TRPV5 were amplified by PCR using  mouse kidney cDNA  
(NH2-tail forward: 
· 5’ CCGAATTCGGATGGGGGCTAAAACTCCTTGGATC 3’;  
· reverse 5’ CGCGCTCGAGCTCAAGGCTGTCCATATTTCTTCCACTT 3’;  
COOH-tail forward: 
·  5’ CCCCTGGGATCCGGCGACACTCACTGGCGAGTGGCC 3’;  
· reverse: 5’ ACAGAAGTCGACTCAGAAATGGTAGATCTCCTC 3’),  
digested with EcoRI and XhoI (NH2-tail) or BamHI and SalI (COOH-tail) and 
cloned into pGEX6p-2 vector (Amersham Pharmacia Biotech AB, Uppsala, 
Sweden). pGEX6p-2 constructs were transformed in Escherichia coli BL21 and 
glutathione S-transferase (GST) fusion proteins were expressed and purified 
according to the manufacturer’s protocol (Amersham Pharmacia Biotech AB). 
[35S]methionine labeled full-length TRPV5 and NHERF2 were prepared using a 
reticulocyte lysate system in the presence of canine microsomal membranes 
(Promega Madison, WI) and added to GST or GST-fusion proteins immobilized 
on glutathione-sepharose 4B beads. The binding buffer contained 20 mM Tris-
HCl, pH 7.4, 140 mM NaCl, 0.2% (w/v) Triton-X-100 and 0.2% (v/v) NP-40, 
supplemented with 1 mM CaCl2 or 2 mM EDTA. After 2 h incubation at room 
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temperature, the beads were washed extensively with binding buffer. Bound 
proteins were eluted with SDS-PAGE loading buffer, separated on SDS-PAGE 
gels and visualized by autoradiography. 
The NHERF2DP1 and NHERF2DP2 constructs prepared by PCR were cloned 
into pGEX-4T (Amersham Pharmacia Biotech AB) and also expressed as GST 
fusion proteins in Escherichia coli. [35S]methionine labeled SGK1 was prepared 
using the TNT in vitro transcription-translation system (Promega Madison, WI). 
4 µg of GST fusion proteins immobilized on glutathione-agarose beads were 
incubated with 5 µl of 35S-labeled SGK1 for 4 h at 4°C in binding buffer 
containing 10 mM Tris pH 7.2, 150 mM NaCl, 0.2% Tween 20. After the 
incubation time, the beads were washed extensively with binding buffer. Bound 
proteins were eluted with SDS-PAGE loading buffer, separated on SDS-PAGE 
gels and visualized by autoradiography. 
 
2.7 Detection of cell surface expression by chemiluminescence 
Defolliculated oocytes were first injected with NHERF2 cRNA (5 ng/oocyte) 
and/or S422DSGK1 cRNA (12 ng/oocyte), and two days later with ROMK1-HA 
cRNA (90 pg/oocyte). Oocytes were prepared for the surface labeling assay as 
recently described (Zerangue et al., 1999, Konstas et al., 2001), with 1 µg/ml 
primary, rat monoclonal anti-HA (hemagglutinin) antibody (clone 3F10, 
Boehringer), and 2 µg/ml secondary, peroxidase-conjugated affinity-purified 
F(ab’)2 goat anti-rat IgG antibody (Jackson ImmunoResearch). Oocytes were 
incubated in primary antibody for 180 min and in secondary antibody for 90 min 
at room temperature. Individual oocytes were placed in 50 µl of SuperSignal 
ELISA Femto Maximum Sensitivity Substrate (Pierce), and chemiluminescence 
was quantified in a Turner TD-20/20 luminometer (Sunnyvale, CA) by 
integrating the signal over a period of 15 s. Results are given in relative light 
units (RLU/s/oocyte). Nonexpressing oocytes were not included in the analysis 
and were defined as those with a surface expression value within one standard 
deviation (SD) of the mean of water-injected oocytes from the same batch. 
Materials and Methods 
   
 
59  
For parallel electrophysiological, analysis injected oocytes were kept in modified 
Barth’s solution and were studied approximately 16 h after injection with 
ROMK1-HA cRNA. Oocytes were routinely clamped at a holding potential of -80 
mV. The barium-sensitive current (DIBa2+) was determined as the difference in 
current between the presence and absence of 10 mM barium in a KCl solution 
(in mM: 95 KCl, 1 CaCl2, 1 MgCl2, 10 HEPES, adjusted to pH 7.4 with TRIS). 
 
2.8 Cell surface biotinylation 
For cell surface biotinylation, 55-75 oocytes of each group were rinsed three 
times with ice-cold PBS buffer (pH 8.0). The oocytes were then incubated 30 
min at room temperature in 0.5 mg/ml Sulfo-NHS-LC-Biotin (Pierce, Rockford, 
IL, USA) diluted in PBS buffer. After washing 4 times with ice-cold PBS, the 
cells were dissolved in lysis buffer containing 50 mM Tris (pH 7.5), 0.5 mM 
EDTA (pH 8.0), 0.5 mM EGTA, 100 mM NaCl, 1% Triton X-100, 25 µg/ml 
aprotinine and 25 µg/ml leupeptin for 30 min on ice. The solubilized oocytes 
were centrifuged for 15 min at 14000 rpm, and then the supernatant was 
incubated with 50 µl of ImmunoPure immobilized streptavidin beads at 4°C over 
night. The biotin-streptavidin-agarose bead complexes were then washed 4 
times with lysis buffer. The final pellets were dissolved in 20 µl sample buffer 
and boiled for 5 min for SDS-PAGE. 
The biotinylated membrane proteins were separated by 8% SDS-PAGE and 
transferred electrophoretically to nitrocellulose membranes. After blocking with 
5% non-fat dry milk in PBS (pH 7.4)/0.15% Tween 20 for 1h at room 
temperature, the blots were incubated with the primary rabbit anti-ROMK1 
antibody (Chemicon, USA) at 4°C overnight (dilution 1:250 in PBS/0.15% 
Tween 20/2.5% non-fat dry milk). After washing, the first antibody was detected 
by secondary sheep anti-rabbit IgG antibody conjugated with horseradish 
peroxidase for 1 h at room temperature. Antibody binding was detected with the 
enhanced chemoluminescence ECL kit (Amersham, Freiburg) and exposure to 
X-ray film. 
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2.9 Western blotting and immunohistochemistry for ROMK1 
For determination of ROMK1 expression in whole cell lysates, 30 cells of each 
group were homogenized in lysis buffer containing 50 mM Tris (pH 7.5), 0.5 mM 
EDTA (pH 8.0), 0.5 mM EGTA, 100 mM NaCl, 1% Triton X-100 and protein 
inhibitor cocktail (Roche) at the recommended concentrations. Proteins were 
transferred to nitrocellulose membranes at 100 V for 90 min. For 
immunoblotting, rabbit anti-ROMK1 antibody (diluted 1:250 in PBS/0.15% 
Tween 20/5% non-fat dry milk) was used to detect ROMK1. After blocking with 
5% non-fat dry milk in PBS/ 0.15% Tween 20/for 1 h at room temperature, blots 
were incubated with the primary antibody at 4°C overnight. Secondary 
peroxidase-conjugated sheep anti-rabbit IgG (diluted 1:1000 in PBS/0.15% 
Tween 20/5% non-fat dry milk) was used for luminescent detection with an 
enhanced chemoluminescence (ECL) kit (Amersham, Freiburg). 
Oocytes for immunohistochemistry were devitellinized and fixed in Dent’s 
solution (80% Methanol, 20% DMSO) overnight at -20°C. After washing with 
PBS, permeabilization and blocking were performed at room temperature for 30 
min by incubation in PBS containing 0.2% Triton-100 and 10% normal goat 
serum. Then oocytes were incubated with rabbit anti-ROMK1 antibody (dilution 
1:250) at 4°C for 12 h. The secondary Alexa-488 coupled goat anti-rabbit 
antibody (Molecular Probes, The Netherlands, dilution 1:200) was added at 4°C 
for 12 h. The embedding procedure in acrylamide (Technovit 7100) was carried 
out according to the manufacturer’s instructions (Heraeus Kulzer, Wehrheim). 
Embedded oocytes were cut into 5 µm sections and analysed with a 
fluorescence microscope (Optiphot, Düsseldorf). 
 
2.10 Immunohistochemistry for CIC-Ka/barttin channels 
Prior to embedding (Tissue-Tek, Miles Inc., Elkhardt, USA) and cutting, 
Xenopus oocytes expressing the indicated epitope-tagged constructs (HA-
epitope for ClC-Ka and V5 epitope for barttin) were fixed in 4% 
paraformaldehyde in PBS at 4°C overnight. 5 µM cryosections were blocked for 
30 min in PBS containing 10% (v/v) normal goat serum (Sigma-Aldrich, 
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Deisenhofen), 0.2% (w/v) bovine serum albumin (Sigma-Aldrich, Deisenhofen), 
and 0.3% (v/v) Triton X-100. The primary antibodies (rat monoclonal anti-HA, 
Roche, Mannheim; mouse monoclonal anti-V5, Invitrogen, Karlsruhe) were 
diluted in the blocking solution (anti-HA 1/400, anti-V5 1/2000) and added to the 
slices for two hours at room temperature. After the slices were washed with 
PBS, secondary Cy-2- or Cy-3-coupled antibodies (Amersham Pharmacia 
Biotech, Freiburg) were added at the recommended dilutions for two hours at 
room temperature. Afterwards the slices were again washed with PBS and 
mounted with glycerol-gelatin (Sigma, Deisenhofen). Epifluorescence 
microscopy was used to detect antibody localization. 
 
2.11 Uptake measurements 
Calcium uptake was measured similar to what has been described earlier (Peng 
et al., 1999, 2000; Hoenderop et al., 2001b) with slight modifications. In detail, 
uptake of 45Ca2+ (ICN Biomedicals GmbH, Eschwege), delivered as CaCl2 in 
aqueous solution (specific activity: 0.185-1.11 TBq/g Ca2+) was determined 3 
days after injection of oocytes with the respective cRNAs by incubating 10-15 
oocytes at 20°C in uptake solution containing 96 mM NaCl, 2 mM KCl, 1 mM 
MgCl2, 0.1 mM CaCl2, 1 mM BaCl2, 10 µM methoxyverapamil, 5 mM HEPES-
Tris, pH 7.4. Radioactive 45Ca2+ was added to give a final concentration of 7 µCi 
per ml. After different incubation times, the oocytes were washed three times in 
stop buffer containing 96 mM NaCl, 1 mM MgCl2, 0.5 mM CaCl2, 1.5 LaCl3, 5 
mM HEPES-Tris, pH 7.4. Single oocytes were then placed separately in 
scintillation vials and solubilized in 200 µl 10% (w/v) sodium dodecyl sulfate. 
After addition of 3 ml scintillation fluid (Ultima Gold, Packard, Groningen, The 
Netherlands), radioactivity in the samples was measured in a liquid scintillation 
counter (Wallac, Freiburg). 
 
2.12 Data evaluation 
Data are expressed as means ± SEM, n represents the number of oocytes and 
N represents the number of batches investigated. All experiments were 
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repeated with at least 3 batches of oocytes from different frogs; in all repetitions, 
qualitatively similar data were obtained. All data were tested for significance 
using the Student t-test, and only results with P < 0.05 were considered 
statistically significant. 
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3.1 Regulation of the renal epithelial K+ channel ROMK1 (Kir1.1a) 
 
3.1.1 Up-regulation of ROMK1 by SGK1 and NHERF2 
As shown in Fig. 18, the injection of cRNA encoding ROMK1 led to the 
expression of a K+ current of 7.3 ± 0.4 µA (n = 35). The current was almost 
completely inhibited by addition of 10 mM K+ channel blocker Ba2+. No 
significant increase of the K+ current was observed after coinjection of the 
constitutively active kinase S422DSGK1 together with ROMK1 (7.0 ± 0.4 µA, n = 
35) under conditions where ENaC-mediated Na+ currents were stimulated five-
fold (Wagner et al., 2001). Similarly, the coexpression of NHERF2 together with 
ROMK1 did not significantly enhance the current (8.2 ± 0.3 µA, n = 35). In 
contrast, the coexpression of S422DSGK1 together with NHERF2 and ROMK1 
led to a statistically significant increase of the current (17.5 ± 1.3 µA, n = 35). In 
oocytes not injected with ROMK1 (not shown), the K+-current was negligible 
(0.05 ± 0.01 µA, n = 6) and not significantly increased by injection of S422DSGK1 
(0.06 ± 0.01 µA, n = 6), NHERF2 (0.05 ± 0.01 µA, n = 6) or both, S422DSGK1 and 
NHERF2 (0.06 ± 0.01 µA, n = 6). 
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Fig. 18. Up-regulation of the renal epithelial K+ channel ROMK1 by SGK1 
and NHERF2. Xenopus laevis oocytes were injected with cRNA of 
ROMK1 alone or with S422DSGK1 (SGK1) and/or NHERF2. Addition of 
10 mM Ba2+ nearly completely inhibited outward K+ current. Only the 
combined coexpression of S422DSGK1 (SGK1) and NHERF2 increases 
ROMK1 channel activity. Arithmetic means ± SEM (n = 35). * indicates 
significant difference between expression of ROMK1 alone and 
coexpression of ROMK1 together with S422DSGK1 (SGK1) and 
NHERF2. 
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3.1.2 Current-Voltage relationship (I-V) of ROMK1 expressing oocytes 
The stimulation of ROMK1 channel activity was not paralleled by profound 
alterations of voltage dependence. As shown in Fig. 19, the relative I-V relation 
was not significantly affected by the combined coexpression of S422DSGK1 and 
NHERF2. 
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Fig. 19. I-V relationship of ROMK1 expressing oocytes. The current (I) as a 
function of the potential difference across the cell membrane (V) in 
oocytes injected with ROMK1 alone (left) and in oocytes injected with 
ROMK1 together with NHERF2 and S422DSGK1 (right) at both, 2 mM K+ 
(open symbols) and 20 mM K+ (closed symbols). Arithmetic means ± 
SEM (n = 6). 
 
3.1.3 Inhibition of ROMK1 by cytosolic acidification 
Given the exquisite pH sensitivity of ROMK1, the stimulating effect of SGK1 and 
NHERF2 could in theory have been due to cytosolic alkalinization or due to 
alteration of pH sensitivity of the channel. According to ion-selective 
microelectrodes, the cytosolic pH values approached 7.11 ± 0.02 (n = 5) in 
oocytes expressing ROMK1 alone and 7.11 ± 0.04 (n = 5) in oocytes expressing 
ROMK1 together with SGK1 and NHERF2. Moreover, ROMK1 retained its pH 
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sensitivity after coexpression of SGK1 and NHERF2. ROMK1 channel activity 
was almost abolished by cytosolic acidification with butyrate in both oocytes 
expressing ROMK1 alone and in oocytes coexpressing ROMK1 together with 
SGK1 and NHERF2 (Fig. 20). 
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Fig. 20. Inhibition of ROMK1 activity by cytosolic acidification. Influence of 
extracellular pH (pH 7.4 or 6.5) and of intracellular acidification by 
addition of 3 mM butyrate on ROMK1-induced current in oocytes 
expressing ROMK1 alone (B, C) or together with S422DSGK1 and 
NHERF2 (A, D). Upper panels, original tracings; lower panels, I-V 
curves. Arithmetic means ± SEM (n = 5-9). 
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3.1.4 pH sensitivity of ROMK1 
However, a detailed analysis of pH dependence revealed a small, but significant 
shift of pKa of ROMK1 towards more acidic values upon coexpression of 
S422DSGK1 (SGK1) and NHERF2 (Fig. 21). To explore whether this shift was 
secondary to the enhanced K+ channel activity, an additional series was 
performed on oocytes injected with 20 ng ROMK1 alone. As illustrated in Fig. 
21 and Tab. 8, the pKa values were not significantly modified by higher ROMK1 
channel expression. Even though statistically significant, the small shift of 
ROMK1-pH sensitivity upon coexpression of S422DSGK1 (SGK1) and NHERF2 
was not sufficient to explain the strong activation of the channel. 
 
Table 8: pH sensitivity of ROMK1 in the absence or presence of S422DSGK1 
(SGK1) plus NHERF2 
 
Clone pKa Imax No. of oocytes
ROMK1 (5 ng) 6.95 ± 0.04 3845 ± 362 9
ROMK1 (5 ng) + SGK1 + NHERF2 6.87 ± 0.04 9331 ± 1500 9
ROMK1 (20 ng) 6.96 ± 0.02 6635 ± 1596 3
*
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Fig. 21. Proton sensitivity of ROMK1 is shifted upon coexpression with 
S422DSGK1 (SGK1) and NHERF2. Ordinate: normalized inward current 
of oocytes expressing either ROMK1 alone (5 ng, ?; 20 ng, ?) or 
ROMK1 together with NHERF2 and S422DSGK1 (¦ ). Arithmetic means 
± SEM (n = 3-9). Currents at different values of internal pH (pHi) were 
normalized to the maximum inward conductance for that oocyte. 
Abscissa: intracellular pH (pHi), as controlled by variation of 
extracellular pH (pHo) in the presence of 3 mM butyrate (see insert). 
 
3.1.5 SGK1 determines pH sensitivity of ROMK1 
As illustrated in Fig. 22, the expression of wild type ROMK1, S44AROMK1 and 
S44DROMK1 induced a K+ current in Xenopus oocytes (IKR) which was highly 
sensitive to the cytosolic pH (pHi). The maximal IKR obtained at pHi 7.3 (Imax) 
was significantly larger in S44DROMK1 expressing oocytes (14.3 ± 2.5 µA, n = 5) 
than in oocytes expressing wild type ROMK1 (4.5 ± 0.7 µA, n = 9). Imax was 
significantly lower in oocytes injected with S44AROMK1 (0.9 ± 0.2 µA, n = 9) than 
in oocytes expressing wild type ROMK1. The cytosolic pH required for 
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halfmaximal IKR (pKa) amounted to 7.05 ± 0.01 for wild type ROMK1. pKa was 
shifted to slightly more alkaline values (7.07 ± 0.02, n = 9) following 
replacement of the serine by alanine (S44AROMK1) and to more acidic values 
(6.83 ± 0.05, n = 5) following replacement of the serine by aspartate 
(S44DROMK1). The mutations did not only modify pH sensitivity but as well the 
maximal activity of the channels. The activity at pH 7.3 was S44DROMK1 > wild 
type ROMK1 > S44AROMK1 (Fig. 22). 
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Fig. 22. K+ currents (IKR) in Xenopus oocytes injected with wild type 
ROMK1, S44AROMK1 or S44DROMK1. (A) Original recordings from 
oocytes expressing wild type ROMK1, S44AROMK1 or S44DROMK1; (B) 
Arithmetic means ± SEM (n = 5-9) of the maximal current (Imax) at pHi 
of 7.3; (C) Arithmetic means ± SEM (n = 5-9) of IKR (in fractions of 
Imax) as a function of pHi. 
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The coexpression of S422DSGK1 and NHERF2 enhanced the activity (Imax) of 
wild type ROMK1 (Fig. 23), of S44AROMK1 (Fig. 24) and of S44DROMK1 (Fig. 25). 
Thus, an intact SGK1 phosphorylation consensus sequence was not required 
for increase of Imax by SGK1 and NHERF2. At high S44DROMK1 expression 
rates (injection of 5 ng S44DROMK1 cRNA) the current could not be further 
stimulated by S422DSGK1 and NHERF2. The injection of lower channel cRNA 
levels (0.5 ng), however, disclosed the ability of S422DSGK1 and NHERF2 
coexpression to enhance S44DROMK1 activity (Fig. 25). 
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Fig. 23. Effect of S422DSGK1 with or without NHERF2 coexpression on 
ROMK1 mediated K+ currents. (A) Original recordings from oocytes 
expressing wild type ROMK1 with or without S422DSGK1 with or 
without NHERF2; (B) Arithmetic means ± SEM (n = 9) of the maximal 
current (Imax) at pHi of 7.3 in oocytes expressing wild type ROMK1 
with or without S422DSGK1 and with or without NHERF2; (C) Arithmetic 
means ± SEM (n = 9) of IKR (in fractions of Imax) as a function of 
cytosolic pH (pHi) in oocytes expressing wild type ROMK1 with or 
without S422DSGK1 and with or without NHERF2. 
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In contrast to regulation of Imax by S422DSGK1 and NHERF2, the regulation of pH 
sensitivity was dependent on an intact SGK1 phosphorylation consensus 
sequence. S422DSGK1 and NHERF2 led to a significant shift of pKa only in wild 
type ROMK1 (to 6.95 ± 0.03, n = 9, Fig. 23), but neither in S44AROMK1 (Fig. 24) 
and S44DROMK1 (Fig. 25). Wild type ROMK1 pKa was shifted by S422DSGK1 
even in the absence of NHERF2 (to 6.97 ± 0.02, n = 9, Fig. 23). 
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Fig. 24. Effect of coexpression of S422DSGK1 and NHERF2 on S44AROMK1 
mediated K+ currents. (A) Original recordings from oocytes 
expressing S44AROMK1 with or without S422DSGK1 and NHERF2; (B) 
Arithmetic means ± SEM (n = 9) of the maximal current (Imax) at pHi of 
7.3 in oocytes expressing S44AROMK1 with or without S422DSGK1 and 
NHERF2; (C) Arithmetic means ± SEM (n = 9) of IKR (in fractions of 
Imax) as a function of cytosolic pH (pHi) in oocytes expressing 
S44AROMK1 with or without S422DSGK1 and NHERF2. 
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The shifts of pKa in wild type ROMK1 following coexpression of S422DSGK1 and 
NHERF2 or S422DSGK1 alone were both significantly different from the 
respective shifts in S44AROMK1 and S44DROMK1. 
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Fig. 25. Effect of coexpression of S422DSGK1 and NHERF2 on S44DROMK1 
mediated K+ currents. (A) Original recordings from oocytes 
expressing S44DROMK1 with or without S422DSGK1 and NHERF2; (B) 
Arithmetic means ± SEM (n = 9) of the maximal current (Imax) at pHi of 
7.3 in oocytes injected with 5 or 0.5 ng S44DROMK1 with or without 
S422DSGK1 and NHERF2; (C) Arithmetic means ± SEM (n = 9) of IKR (in 
fractions of Imax) as a function of cytosolic pH (pHi) in oocytes 
expressing S44DROMK1 with or without S422DSGK1 and NHERF2. 
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3.1.6 Increase of ROMK1 abundance in the cell membrane 
Data from a number of reports have suggested that SGK1 stimulates ENaC-
mediated Na+ current by augmenting channel abundance in the plasma 
membrane (Alvarez de la Rosa et al., 1999; Loffing et al., 2001b; Wagner et al., 
2001). To determine the effect of SGK1 and NHERF2 on ROMK1 abundance in 
the plasma membrane, western blot and immunohistochemistry were performed 
on cell membranes from oocytes expressing ROMK1 together with SGK1 and 
NHERF2 and in oocytes expressing ROMK1 alone. As shown in Fig. 26A, 
SGK1 and NHERF2 did indeed stimulate ROMK1 plasma membrane 
abundance as determined by densitometry of western blots of biotinylated 
membranes. Moreover, determination of cell surface expression by 
chemiluminescence again disclosed the stimulating effect of SGK1/NHERF2 on 
ROMK1 cell surface expression (Fig. 27). Increased expression of ROMK1 in 
the plasma membrane was not due to de novo protein synthesis because 
western blots from whole cell lysates did not show any difference in ROMK1 
expression in oocytes injected with ROMK1, SGK1 and NHERF2 as compared 
to those injected with ROMK1 alone (Fig. 26B). 
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Fig. 26. Increase of ROMK1 abundance in the cell membrane by 
coexpression of SGK1 and NHERF2. (A) Expression of ROMK1 in 
the cell membrane. In oocytes expressing S422DSGK1 and NHERF2, 
the abundance of ROMK1 channel protein at the surface of the 
oocyte membrane is significantly increased. ROMK1 abundance in 
oocytes expressing ROMK1 alone (R) and expressing ROMK1 
together with S422DSGK1 and NHERF2 (RNS). Left: Western blot of 
ROMK1 in biotinylated membrane. Ratio of intensity is compared to 
the intensity obtained in oocytes expressing ROMK1 alone (R). N.I., 
for not injected oocytes; + denotes significant difference between 
oocytes injected with ROMK1 and those injected with water; * 
indicates significant difference between expression of ROMK1 alone 
and coexpression of ROMK1 together with S422DSGK1 and NHERF2 
(RNS). Arithmetic means ± SEM (n = 30). Right: 
Immunohistochemistry. ROMK1 staining in the cell membrane of 
oocytes expressing S422DSGK1 and NHERF2 (RNS) is higher than in 
oocytes expressing ROMK1 alone (R). (B) Expression of ROMK1 in 
whole cell lysates. In oocytes expressing S422DSGK1 and NHERF2, 
the abundance of ROMK1 channel protein in whole cell lysates is not 
modified significantly as compared to those expressing ROMK1 
alone. RS, for oocytes injected with ROMK1 together with 
S422DSGK1. Ratio of intensity is compared to the intensity obtained in 
oocytes expressing ROMK1 alone (R). + denotes significant 
difference between oocytes injected with ROMK1 and those injected 
with water. Arithmetic means ± SEM (n = 6). 
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In an additional series of experiments were performed to examine whether 
ROMK1-HA surface expression was stimulated using a chemiluminescence 
assay in parallel with DIBa2+ measurements. Fig. 27 summarises results from 
one of three similar experiments. These results demonstrate that both surface 
expression and DIBa2+ are increased in oocytes expressing 
SGK1/NHERF2/ROMK1-HA oocytes as compared with SGK1/ROMK1-HA 
control oocytes. Coexpression of NHERF2 increased DIBa2+ by 232% and 
ROMK1-HA surface labelling by 227%. Increasing the surface expression of 
ROMK1-HA is sufficient to explain the stimulation of DIBa2+ in oocytes 
coexpressing SGK1/NHERF2 and ROMK1-HA. 
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Fig. 27. Determination of ROMK1 surface expression by 
chemiluminescence. Surface expression of extracellularly HA-
tagged ROMK1 and DIBa2+ were assessed in parallel in oocytes 
coexpressing S422DSGK1 + ROMK1-HA and in oocytes from the 
same batch coexpressing S422DSGK1 + NHERF2 + ROMK1-HA. 
Water-injected control oocytes were used to determine 
nonspecific chemiluminescence and endogenous DIBa2+. Both 
DIBa2+ (open bars) and surface expression of ROMK1-HA (filled 
bars) were significantly increased in S422DSGK1 + NHERF2 + 
ROMK1-HA oocytes compared with S422DSGK1 +ROMK1-HA 
control oocytes (*, p < 0.05; **, p < 0.01; ***, p < 0.001). Numbers 
above bars represent the number of oocytes studied. 
Chemiluminescence as a measure of surface expression is given 
in relative light units per 15 sec per oocyte (RLU/15 s per oocyte). 
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3.1.7 Influence of SGK1 and NHERF2 coexpression on ROMK1 stability 
In principle, SGK1 and NHERF2 could increase plasma membrane ROMK1 
expression by increasing channel insertion, decreasing removal, or a 
combination of the two. To distinguish these possibilities, K+ currents were 
monitored in oocytes exposed to brefeldin A (5 µM), which blocks cellular 
secretory mechanisms by inhibiting vesicle formation at the Golgi apparatus, 
during different time points (0, 4, 8, 12, and 24 h). The treatment did not affect 
viability of the oocytes, and the cell membrane potential of noninjected oocytes 
approached -40 ± 7 mV (n = 24) before and -41 ± 6 mV (n = 24) following a 24 h 
exposure to brefeldin A. The respective values for nontreated oocytes were -40 
± 4 mV (n = 24) and -42 ± 4 mV (n = 24) before and after 24 h incubation in 
brefeldin-free buffer. Incubation of oocytes expressing ROMK1 in brefeldin A (5 
µM)-containing solution led to a gradual decrease of channel activity, which was 
significantly and rapidly decreased after 24 h incubation in oocytes expressing 
ROMK1 alone as compared with oocytes expressing ROMK1 together with 
SGK1 and NHERF2 (Fig. 28). This finding points to a stabilizing effect of SGK1 
plus NHERF2 coexpression on ROMK1 channel protein in the plasma 
membrane. 
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Fig. 28. Influence of SGK1 and NHERF2 coexpression on ROMK1 stability. 
Influence of 5 µM brefeldin A (BFA) on ROMK1 channel activity with or 
without coexpression of NHERF2 plus S422DSGK1 (SGK1). 
Coexpression of S422DSGK1 (SGK1) plus NHERF2 blunts the decrease 
of channel activity in brefeldin treated oocytes, determined after 24 h 
incubation (in A) and at the indicated time points (in B). Arithmetic 
means ± SEM (n = 6). * indicates significant difference between 
expression of ROMK1 (R) alone and coexpression of ROMK1 together 
with S422DSGK1 (SGK1) and NHERF2 (RSN). 
 
3.1.8 Stimulation of ROMK1 requires second PDZ domain of NHERF2 
As shown in Fig. 29, SGK1 is able to bind GST-tagged NHERF2. SGK1 does 
not only bind to the full length NHERF2 (GST-NHERF2) but as well to the 
isolated second PDZ domain (GST-P2) of NHERF2. In contrast, the isolated 
first PDZ domain (GST-P1) and GST alone do not bind SGK1. 
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Fig. 29. Binding of SGK1 to NHERF2. Dependence on the second PDZ 
domain. 4 µg of GST fusion proteins encoding full length NHERF2, 
the first or second PDZ domain of NHERF2 immobilized on 
glutathione-agarose beads (GST-P1, GST-P2) were incubated with 5 
µl of 35S-labeled SGK1 for 4 h at 4°C in binding buffer. After the 
incubation time, the beads were washed extensively and bound 
proteins were eluted with SDS-PAGE loading buffer, separated on 
SDS-PAGE gels and visualized by autoradiography. Note that SGK1 
interacts with the second PDZ (P2) domain of NHERF2 and with the 
first PDZ (P1) domain only very weakly. 
 
The second PDZ domain of NHERF2 is further required for the stimulating 
effect of NHERF2 and S422DSGK1 (SGK1) on the ROMK1 induced K+ current IKR 
(Fig. 30). IKR is markedly enhanced by coexpression of ROMK1 together with 
both, constitutively active S422DSGK1 and wild type NHERF2 (from 5.1 ± 0.5 µA 
in ROMK1 expressing oocytes (n = 16) to 13.8 ± 0.8 µA in oocytes expressing 
S422DSGK1/NHERF2/ROMK1, n = 23). Coexpression of S422DSGK1 together with 
NHERF2 deficient of the first PDZ domain (NHERF2DP1) similarly increases IKR 
(12.3 ± 1.4 µA, n = 15). In contrast, coexpression of ROMK1 with S422DSGK1 
and NHERF2 lacking the second PDZ domain (NHERF2DP2) does not yield an 
IKR exceeding that after expression of ROMK1 alone (4.7 ± 0.8 µA, n = 15). 
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Thus, the second PDZ domain is required for the stimulating effect of 
S422DSGK1/NHERF2 on ROMK1. 
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Fig. 30. Requirement of the second PDZ domain of NHERF2 for the 
stimulation of K+ channel activity by constitutively active 
S422DSGK1. Xenopus laevis oocytes were injected with cRNA 
encoding ROMK1, S422DSGK1 (SGK1) and either water, wildtype 
NHERF2, NHERF2 lacking the first PDZ domain (NHERF2DP1) or 
NHERF2 lacking the second PDZ domain (NHERF2DP2). Only the 
combined coexpression of S422DSGK1 and wild type NHERF2 or 
NHERF2DP1 increases ROMK1 channel activity. Arithmetic means ± 
SEM (n = 15-23). * indicates significant difference between 
expression of ROMK1 alone and coexpression of ROMK1 together 
with S422DSGK1 (SGK1) and NHERF2 or its analogus . 
 
Further studies were performed to identify the requirement for the putative PDZ 
binding motif in the ROMK1 channel protein. As illustrated in Fig. 31, expression 
of a ROMK1 mutant lacking the putative PDZ-binding motif (ROMK1D4) yields a 
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IKR similar to the IKR observed following expression of wild type ROMK1 alone 
(3.5 ± 0.6 µA in ROMKD4 expressing oocytes (n = 27) and 3.2 ± 0.3 µA in 
ROMK1 expressing oocytes (n = 25). However, the additional coexpression of 
S422DSGK1/NHERF2 increases IKR only in Xenopus oocytes expressing wild type 
ROMK1. Thus, the putative PDZ binding motif in the ROMK1 channel protein is 
required for the interaction with S422DSGK1/NHERF2. 
 
0
2
4
6
8
C
ur
re
nt
 (
µA
)
RO
MK
1 +
 H
2
O
RO
MK
1 +
 
S4
22
D SG
K1
 + 
NH
ER
F2
RO
MK
D 4
 + 
H 2
O
RO
MK
D4
 + 
S4
22D
SG
K1
 + 
NH
ER
F2
*
 
 
Fig. 31. Requirement of the COOH-terminal PDZ binding motif in ROMK1 
for the stimulation by S422DSGK1/NHERF2. Xenopus laevis oocytes 
were injected with cRNA encoding either wild type ROMK1 or ROMK1 
lacking the PDZ binding motif present at the COOH-terminal end 
(ROMK?4) with or without additional injection with constitutively active 
S422DSGK1 (SGK1) and wildtype NHERF2. Wild type ROMK1 but not 
ROMK1 lacking the PDZ binding motif is up-regulated by the additional 
expression of S422DSGK1/NHERF2. Arithmetic means ± SEM (n = 25-
27). * indicates significant difference between expression of ROMK1 
alone and coexpression of ROMK1 together with S422DSGK1 (SGK1) 
and NHERF2. 
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The PDZ domains of NHERF2 are thought to link NHERF2 and associated 
proteins to the cytoskeleton and thus to accomplish the targeting to or 
stabilization of transport proteins in the cell membrane (Yun et al., 1998; 
Shenolikar and Weinmann, 2001; Biber, 2001; Yun, 2003). Therefore the 
ROMK1 surface expression was examined, using a chemiluminescence assay 
in parallel with electrophysiological measurements, upon coexpression of 
NHERF2 and ROMK1 mutants. Fig. 32 demonstrates that both surface 
expression (in A) and current (in B) are increased in oocytes expressing 
S422DSGK1/NHERF2/ROMK1 compared with ROMK control oocytes. 
Coexpression of S422DSGK1/NHERF2 increased ROMK1-HA surface labeling 4-
fold and ROMK1-mediated currents from 0.6 ± 0.2 µA in ROMK1 expressing 
oocytes (n = 12) to 5.6 ± 1.4 µA in oocytes expressing 
S422DSGK1/NHERF2/ROMK1 (n = 12). ROMK1-HA surface expression was also 
enhanced up to 3.8-fold upon coexpression of S422DSGK1 and NHERF2 lacking 
the first PDZ domain (NHERF2DP1). However, coexpression of NHERF2 
lacking the second PDZ domain failed to increase ROMK1 expression and 
ROMK1-mediated currents (0.6 ± 0.2 µA in ROMK1 expressing oocytes (n = 12) 
vs. 1.2 ± 0.3 µA in oocytes expressing S422DSGK1/NHERF2DP2/ROMK1, n = 
12). No changes in ROMK1 expression or activity by S422DSGK1/NHERF2 was 
observed when the PDZ binding motif at the COOH-terminal end of ROMK1 
was deleted (3.2 ± 0.4 µA in ROMK1D4 expressing oocytes (n = 12) compared 
to 3.4 ± 0.8 µA in oocytes expressing S422DSGK1/NHERF2/ROMK1D4, n = 12). 
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Fig. 32. Determination of ROMK1 surface expression by 
chemiluminescence. Surface expression of extracellularly HA-
tagged ROMK1 and IKR were assessed in parallel in oocytes 
expressing ROMK1-HA alone and in oocytes coexpressing ROMK1-
HA together with S422DSGK1, full-length NHERF2 or NHERF2 lacking 
the first (NHERF2DP1) or second (NHERF2DP2) PDZ domain. Water 
injected control oocytes were used to determine nonspecific 
chemiluminescence and endogenous IKR. Both ROMK1-HA 
expression and IKR were significantly increased upon 
S422DSGK1/NHERF2 expression. Coexpression of S422DSGK1 with 
NHERF2DP2 failed to stimulate ROMK1-HA expression and activity. 
Similarly, S422DSGK1/NHERF2 did not affect ROMK1D4-HA 
expression and activity. Arithmetic means ± SEM (n = 12-20). 
Chemiluminescence as a measure of surface expression is given in 
relative light units per sec per oocyte (RLU/s/oocyte). 
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3.2 Regulation of the renal epithelial Ca2+ channel ECaC1 (TRPV5) 
 
3.2.1 Stimulation of tracer Ca2+ entry via TRPV5 
As evident from Fig.33A, uptake of radioisotope of Ca2+ (45Ca2+) into Xenopus 
oocytes was increased some 7-fold by expression of TRPV5. The increase of 
Ca2+ uptake reflects the Ca2+ transporting capacity of TRPV5. Additional 
expression of either NHERF2, SGK1, SGK2, SGK3 or constitutively active 
T308D,S473DPKB alone did not further stimulate 45Ca2+ entry. However, expression 
of TRPV5 together with both, SGK1 and NHERF2 resulted in significant further 
stimulation of Ca2+ uptake. In the absence of TRPV5, expression of SGK1 and 
NHERF2 did not increase Ca2+ uptake (not shown). Thus, coexpression of 
SGK1 and NHERF2 increase Ca2+ uptake by stimulation of TRPV5. Similarly, 
the coexpression of TRPV5 together with SGK3 and  NHERF2 increased Ca2+ 
uptake. Both kinases stimulate TRPV5, an effect requiring the presence of 
NHERF2. In contrast, the coexpression of neither SGK2 nor T308D,S473DPKB 
significantly modified the Ca2+ uptake into oocytes expressing TRPV5 and 
NHERF2. 
Thus, SGK1 and SGK3, but not SGK2 or T308D,S473DPKB stimulate TRPV5 in the 
presence of NHERF2. As illustrated in Fig. 33B, constitutively active S422DSGK1 
coexpressed with TRPV5 and NHERF2 similarly stimulated Ca2+ entry. Up to 60 
min, Ca2+ entry was linear in oocytes expressing TRPV5 alone or together with 
S422DSGK1 and NHERF2. 
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Fig. 33. Stimulation of tracer Ca2+ entry by the combined expression of 
TRPV5, NHERF2 and SGK1 or SGK3 but not SGK2 or protein 
kinase B. 
(A) Xenopus laevis oocytes were injected with either water or cRNA 
encoding TRPV5 and NHERF2 with or without coinjection of cRNA 
encoding wild type NHERF2, SGK1, SGK2, SGK3 or constitutively 
active T308D,S473DPKB. 45Ca2+ uptake was measured after 30 min of 
incubation. Arithmetic means ± SEM (n = 8-10). * denotes significant 
difference (p < 0.05) between Xenopus oocytes expressing TRPV5 
alone and oocytes expressing TRPV5 together with NHERF2 and the 
respective kinase. 
(B) 45Ca2+ uptake after 1, 10, 30 and 60 min in oocytes expressing 
TRPV5 and oocytes expressing TRPV5 together with S422DSGK1 and 
NHERF2. Arithmetic means ± SEM (n = 6-10). 
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3.2.2 Inhibitory effect of chelerythrine on tracer Ca2+ entry 
In earlier studies, the stimulation of ENaC by SGK1 was shown to be reversed 
by the kinase inhibitor chelerythrine (Lang et al., 2000). As illustrated in Fig. 34, 
10 µM chelerythrine indeed decreased Ca2+ uptake into TRPV5 expressing 
oocytes. 
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Fig. 34. Inhibitory effect of chelerythrine on tracer Ca2+ entry. Xenopus 
laevis oocytes were injected with water alone or TRPV5 with or 
without cRNA encoding S422DSGK1 and NHERF2. Ca2+ entry via 
TRPV5 with or without S422DSGK1 and NHERF2 was partially inhibited 
by addition of 10 µM chelerythrine. Arithmetic means ± SEM (n = 6-8). 
* denotes significant difference (p < 0.05) between Xenopus oocytes 
expressing TRPV5 and oocytes injected with water. + denotes 
significant difference (p < 0.05) between Xenopus oocytes expressing 
TRPV5 together with S422DSGK1 and NHERF2 and oocytes expressing 
TRPV5 alone. 
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3.2.3 Inhibition of tracer Ca2+ uptake by ruthenium red 
Previously, TRPV5 has been shown to be inhibited by ruthenium red 
(Hoenderop et al., 2001b), a polycationic dye. Thus, the effect of ruthenium red 
on Ca2+ uptake has been tested. As shown in Fig. 35, 5 µM ruthenium red 
completely abolished the increase of Ca2+ uptake in TRPV5 expressing oocytes 
with or without additional expression of S422DSGK1 and NHERF2. 
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Fig. 35. Inhibition of tracer Ca2+ uptake by ruthenium red. Xenopus laevis 
oocytes were injected with water alone or TRPV5 with or without cRNA 
encoding S422DSGK1 and NHERF2. Application of 5 µM ruthenium red 
completely inhibits TRPV5 mediated Ca2+ entry. Arithmetic means ± 
SEM (n = 6-8). * denotes significant difference (p < 0.05) between 
oocytes expressing TRPV5 and oocytes injected with water. + denotes 
significant difference (p < 0.05) between oocytes expressing TRPV5 
together with S422DSGK1 and NHERF2 and oocytes expressing TRPV5 
alone. 
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3.2.4 Ca2+ currents via TRPV5 stimulated by SGK1 and NHERF2 
Further studies have been performed to determine the influence of S422DSGK1 
on TRPV5 induced currents. As reported earlier, the entry of Ca2+ triggers Ca2+ 
sensitive Cl- channels (Hoenderop et al., 1999a). To determine the Ca2+ current 
directly, the Cl- channels had to be suppressed. Therefore, the oocytes were 
bathed in Cl- free extracellular fluid for 24 hours. As shown in Fig. 36, the 
addition of 10 mM CaCl2 induced an inward current which was 4.5 fold larger in 
TRPV5 expressing oocytes as compared to water injected oocytes. 
Coexpression of TRPV5 together with S422DSGK1 and NHERF led to a further 
significant increase of the current. In contrast, the current was not increased by 
coexpression of TRPV5 with either NHERF2 or SGK1 alone (Fig. 36A). ICa was 
insensitive to the Cl- channel inhibitor NPPB (Fig. 36B). 
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Fig. 36. Stimulation of Ca2+ currents by the combined expression of 
TRPV5, NHERF2 and the S422DSGK1. 
(A) TRPV5 expressing oocytes but not water injected oocytes show 
an inward currrent upon addition of 10 mM Ca2+ to the bath. 
Coexpression of TRPV5 together with S422DSGK1 and NHERF2 leads 
to a significant increase of the current compared to oocytes 
expressing TRPV5 alone. S422DSGK1 and NHERF2 alone do not alter 
TRPV5 channel activity significantly. Arithmetic means ± SEM (n = 8-
26). * denotes significant difference (p < 0.05) between oocytes 
expressing TRPV5 and oocytes injected with water. + denotes 
significant difference (p < 0.05) between oocytes expressing TRPV5, 
S422DSGK1 together with NHERF2 and oocytes expressing TRPV5 
alone. 
(B) The inward current into TRPV5 expressing oocytes in the 
absence of Cl- induced by high extracellular Ca2+ is not sensitive to 
the chloride channel blocker NPPB. Arithmetic means ± SEM (n = 5-
12). * denotes significant difference (p < 0.05) between oocytes 
expressing TRPV5, S422DSGK1 together with NHERF2 and oocytes 
expressing TRPV5 alone. + denotes significant difference between 
oocytes expressing TRPV5, S422DSGK1 together with NHERF2 and 
oocytes expressing TRPV5 alone under continuous presence of 100 
µM NPPB. 
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3.2.5 TRPV5 activate an endogenous chloride conductance (ICl(Ca)) 
In the presence of Cl-, the Ca2+ entry through TRPV5 stimulated Ca2+ sensitive 
Cl- channels led to the appearance of a large Cl- current (ICl(Ca)). In TRPV5 
expressing oocytes, hyperpolarization from -50 mV to -110 mV in the presence 
of 10 mM Ca2+ triggered a rapidly activating, slowly and partially inactivating 
inward current (Fig. 37C). The transiently activating current was only present in 
Xenopus oocytes expressing TRPV5. In water injected oocytes increase of 
cytosolic Ca2+ activity by addition of Ca2+ ionophore ionomycin (10 µM) led to 
the stimulation of a non inactivating current (Fig. 37B). Fig. 37A depicts a 
recording from a water injected oocyte. Similar to tracer Ca2+ uptake and Ica, 
ICl(Ca) was stimulated by coexpression of TRPV5 together with NHERF2 and 
either, S422DSGK1 (Fig. 38A), SGK1 (Fig. 38B) or SGK3 (Fig. 38B). 
Coexpression of TRPV5 with either NHERF2, S422DSGK1, SGK1 or SGK3 alone 
did not significantly enhance ICl(Ca). Moreover, neither SGK2 nor T308D,S473DPKB 
stimulated ICl(Ca), even when NHERF2 was coexpressed (Fig. 38B). Thus, ICl(Ca) 
was enhanced by SGK1 and SGK3 but not by SGK2 or T308D,S473DPKB and the 
effect of SGK1 and SGK3 required the presence of NHERF2. In oocytes not 
expressing TRPV5, the Ca2+ sensitive Cl- current could be activated by Ca2+ 
ionophore ionomycin (10 µM). As shown in Fig. 38C, the ionomycin induced Cl- 
current was not significantly enhanced by expression of S422DSGK1, NHERF2 or 
both. 
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Fig. 37. Current response to a hyperpolarizing pulse. (A) In water injected 
oocytes, hyperpolarization does not increase any voltage-
dependent current. (B) Elevation of cytosolic Ca2+ by addition of the 
Ca2+ ionophore ionomycin (10 µM) led to the stimulation of a non 
inactivating current. (C) In TRPV5 expressing Xenopus laevis 
oocytes, hyperpolarization from -50 mV to -110 mV in the presence 
of 10 mM Ca2+ triggered a rapidly activating, slowly and partially 
inactivating inward current.  
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Fig. 38. TRPV5 mediated calcium currents indirectly activate an 
endogenous chloride conductance (ICl(Ca)). (A) The endogenous 
chloride conductance (ICl(Ca)) was stimulated by coexpression of 
TRPV5 together with NHERF2 and constitutively active SGK1 
(S422DSGK1) but not with constitutively inactive SGK1 (K127NSGK1). 
(B) ICl(Ca) was enhanced by coexpression of TRPV5 together with 
NHERF2 and either, wild type SGK1 or SGK3 but not with SGK2 
and constitutively active T308D,S473DPKB. Coexpression of TRPV5 
with either NHERF2, S422DSGK1, SGK1 or SGK3 alone did not 
significantly enhance ICl(Ca). Arithmetic means ± SEM (n = 19-26). 
(C) The ionomycin induced endogenous Cl- current was not 
significantly enhanced by expression of S422DSGK1, NHERF2 or 
both. Arithmetic means ± SEM (n = 6). 
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3.2.6 Inhibition of the ICl(Ca) by ruthenium red and NPPB 
Thus, the increase of ICl(Ca) following coexpression of S422DSGK1 and NHERF2 
was not due to up-regulation of the Cl- channel but due to up-regulation of 
TRPV5. As illustrated in Fig. 39, ICl(Ca) was abolished by ruthenium red (Fig. 
39A) and by Cl- channel blocker NPPB (Fig. 39B). 
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Fig. 39. Inhibition of the TRPV5 induced current ICl(Ca) by ruthenium red 
and NPPB. Xenopus laevis oocytes were injected with water alone or 
TRPV5 with or without cRNA encoding S422DSGK1 and NHERF2. (A) 
Inhibition of ICl(Ca) by application of 5 µM ruthenium red. Arithmetic 
means ± SEM (n = 7). (B) Inhibition of ICl(Ca) by application of 100 µM 
NPPB. Arithmetic means ± SEM (n = 5-8). Insert in A depicts dose-
dependent inhibition of TRPV5 activity.* denotes significant difference 
(p < 0.05) between Xenopus oocytes expressing TRPV5 and oocytes 
injected with water. + denotes significant difference (p < 0.05) between 
Xenopus oocytes expressing TRPV5 together with S422DSGK1 and 
NHERF2 and oocytes expressing TRPV5 alone. 
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3.2.7 Interaction of TRPV5 and NHERF2 proteins 
To investigate if the regulatory effect of SGK1 and NHERF2 on TRPV5 activity 
is mediated by protein-protein interaction of NHERF2 and TRPV5, binding 
assays were performed. To this end, full-length [35S]methionine labeled TRPV5 
protein was incubated with GST-NHERF2 fusion protein. TRPV5 interacted with 
GST-NHERF2, whereas no binding to GST alone was observed, indicating the 
specificity of the interaction (Fig. 40A). The binding was identical in the 
presence or absence (2 mM EDTA) of Ca2+ (1 mM). Similarly, GST fusion 
proteins encompassing either the amino- or carboxy-tail of TRPV5 were 
incubated with [35S]methionine labeled NHERF2. NHERF2 interacted 
specifically with the carboxy-tail, while the amino-tail of TRPV5 was unable to 
bind NHERF2 (Fig. 40B). The binding was again Ca2+-independent. 
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Fig. 40. Interaction of TRPV5 and NHERF2 proteins. (A) Full-length 
[35S]methionine labeled TRPV5 protein was incubated with GST-
NHERF2 fusion protein in the presence and absence of 1 mM 
extracellular Ca2+. TRPV5 interacted with GST-NHERF2, whereas no 
binding to GST alone was observed. The binding was identical in the 
presence of 1 mM or absence (2 mM EDTA) of Ca2+. (B) GST fusion 
proteins encompassing either the amino- or carboxy-tail of TRPV5 
were incubated with [35S]methionine labeled NHERF2. NHERF2 
interacted specifically with the carboxy-tail, since the amino-tail of 
TRPV5 and GST alone were unable to bind NHERF2. The binding 
was identical in the presence of 1 mM or absence (2 mM EDTA) of 
Ca2+. 
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3.2.8 Stimulation of TRPV5 requires Second PDZ domain of NHERF2 
Further studies were performed to identify the PDZ binding domain of NHERF2 
required for the stimulating effect of S422DSGK1 and NHERF2 on TRPV5 activity. 
As shown in Fig. 41, ICl(Ca) was markedly enhanced by coexpression of TRPV5 
with both, S422DSGK1 and wild-type NHERF2, but not by coexpression of 
TRPV5 together with S422DSGK1 and NHERF2 lacking the second PDZ domain 
(NHERF2DP2). In contrast, coexpression of S422DSGK1 together with a NHERF2 
mutant deficient of the first PDZ domain (NHERF2DP1) increased ICl(Ca) similar 
to coexpression of S422DSGK1 together with wild type NHERF2. Thus, the 
second but not the first PDZ domain is essential for up-regulation of TRPV5 
activity. This requirement for the second PDZ domain is consistent with the 
interaction of SGK1 with the second but not first PDZ domain of NHERF2 (Yun 
et al., 1998). 
Results 
   
 
101  
C
ur
re
nt
 (
µA
)
0
2
4
6
8
10
*
+
H 2
O
TR
PV
5 +
 H
2
O
TR
PV
5 +
 
S4
22
D SG
K1
 + 
NH
ER
F2
TR
PV
5 +
 
S4
22
D SG
K1
 + 
NH
ER
F2
DP
2
TR
PV
5 +
 
S4
22
D SG
K1
 + 
NH
ER
F2
DP
1
 
 
Fig. 41. Requirement of the second PDZ domain of NHERF2 for the 
stimulation of TRPV5 activity by constitutively active S422DSGK1. 
Xenopus laevis oocytes were injected with water or cRNA encoding 
TRPV5 alone or with S422DSGK1 and either wild-type NHERF2, 
NHERF2 lacking the second PDZ domain (NHERF2DP2) or NHERF2 
lacking the first PDZ domain (NHERF2DP1). Only the combined 
coexpression of S422DSGK1 and wild-type NHERF2 or NHERF2DP1 
increases TRPV5 channel activity. Arithmetic means ± SEM (n = 14-
22) of currents taken at -135 mV. * indicates significant difference 
between expression of TRPV5 alone and of TRPV5 coexpressed with 
S422DSGK1 and NHERF2. + denotes significant difference (p < 0.05) 
between Xenopus oocytes expressing TRPV5 together with 
S422DSGK1 and NHERF2?2 and oocytes expressing TRPV5 alone. 
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3.3 Regulation of the renal CIC-Ka/barttin chloride channels 
 
3.3.1 ClC-Ka/barttin induced currents 
Xenopus oocytes expressing ClC-Ka together with barttin created a slightly 
inwardly rectifying current (ICl) of -0.69 ± 0.06 µA (n = 17-20) at -140 mV. The 
respective current ICl in water injected Xenopus oocytes amounted to -0.06 ± 
0.01 µA (n = 17-20) (Fig. 42). 
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Fig. 42. ClC-Ka/barttin induced currents. Xenopus laevis oocytes were 
injected with water or with cRNA encoding ClC-Ka together with 
barttin. Slightly inwardly rectifying currents are observed in Xenopus 
oocytes expressing ClC-Ka/barttin but not in water injected oocytes. 
(A) Original tracings. (B) Current-voltage relations. (C) Absolute 
current values at a holding voltage of -140 mV. Arithmetic means ± 
SEM (n = 17-20). * indicates significant difference between currents 
in oocytes expressing ClC-Ka/barttin as compared to oocytes 
injected with water. 
 
3.3.2 Regulation of ClC-Ka/barttin channels by Nedd4-2 and SGK1 
As shown in Fig. 43, the coexpression of Nedd4-2 together with ClC-Ka/barttin 
decreased ICl significantly to -0.35 ± 0.03 µA (n = 17). In contrast, coexpression 
of SGK1 with ClC-Ka/barttin significantly enhanced ICl to -0.93 ± 0.07 µA (n = 
18). Moreover, SGK1 reversed the effect of Nedd4-2. In Xenopus oocytes 
coexpressing ClC-Ka/barttin together with both, Nedd4-2 and SGK1, ICl 
approached -1.06 ± 0.07 µA (n = 20). 
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Fig. 43. Regulation of ClC-Ka/barttin induced currents by Nedd4-2 and 
SGK1. Xenopus laevis oocytes were injected with cRNA encoding 
ClC-Ka/barttin with or without cRNA encoding Nedd4-2 and/or SGK1. 
The ClC-Ka/barttin induced currents are down-regulated by 
coexpression of Nedd4-2 and up-regulated by SGK1. (A) Original 
tracings. (B) Current-voltage relations. (C) Absolute current values at 
a holding voltage of -140 mV. Arithmetic means ± SEM (n = 17-20). * 
indicates significant difference between the respective currents and 
the currents in oocytes expressing ClC-Ka/barttin alone. 
 
3.3.3 Regulation of ClC-Ka/barttin channels by SGK1 mutants 
The effect of SGK1 on ICl was mimicked by the constitutively active S422DSGK1 
but not by the inactive mutant K127NSGK1 (Fig. 44). In Xenopus oocytes 
expressing ClC-Ka/barttin together with S422DSGK1, ICl reached -1.06 ± 0.08 µA 
(n = 20), whereas in oocytes expressing ClC-Ka/barttin together with 
K127NSGK1, ICl was -0.56 ± 0.06 µA (n = 17). While coexpression of S422DSGK1 
reversed the effect of Nedd4-2 (ICl = -0.97 ± 0.07 µA, n = 20), the coexpression 
of the inactive mutant K127NSGK1 did not reverse the inhibitory effect of Nedd4-2 
(ICl = -0.48 ± 0.04 µA, n = 18). 
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Fig. 44. Regulation of ClC-Ka/barttin induced currents by constitutively 
active SGK1 but not inactive mutant kinase. Xenopus laevis 
oocytes were injected with cRNA encoding ClC-Ka/barttin with or 
without cRNA encoding Nedd4-2 and/or either constitutively active 
S422DSGK1 or inactive K127NSGK1. S422DSGK1 but not K127NSGK1 
enhances the ClC-Ka/barttin induced currents and reverses the down-
regulation of those currents by Nedd4-2. (A) Original tracings. (B) 
Current-voltage relations. (C) Absolute current values at a holding 
voltage of -140 mV. Arithmetic means ± SEM (n = 17-20). * indicates 
significant difference between the respective currents and the currents 
in oocytes expressing ClC-Ka/barttin alone. 
 
3.3.4 Regulation of ClC-Ka/barttin induced currents by SGK3 
SGK3 but not SGK2 activated ICl similar to SGK1 (Fig. 45). In Xenopus oocytes 
expressing ClC-Ka/barttin together with SGK3 ICl amounted -1.10 ± 0.10 µA (n = 
18), whereas in oocytes expressing ClC-Ka/barttin together with SGK2 ICl was 
only -0.75 ± 0.07 µA (n = 17). While coexpression of SGK3 reversed the effect 
of Nedd4-2 (ICl = -1.31 ± 0.11 µA, n = 20), the coexpression of SGK2 did not 
reverse the inhibitory effect of Nedd4-2 (ICl = -0.47 ± 0.05 µA, n = 18). 
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Fig. 45. Regulation of ClC-Ka/barttin induced currents by SGK3 but not by 
SGK2. Xenopus laevis oocytes were injected with cRNA encoding ClC-
Ka/barttin with or without cRNA encoding Nedd4-2 and/or either SGK2 
or SGK3. SGK3 but not SGK2 enhances the ClC-Ka/barttin induced 
currents and reverses the down-regulation of those currents by Nedd4-
2. (A) Original tracings. (B) Current-voltage relations. (C) Absolute 
current values at a holding voltage of -140 mV. Arithmetic means ± 
SEM (n = 17-20). * indicates significant difference between the 
respective currents and the currents in oocytes expressing ClC-
Ka/barttin alone. 
 
3.3.5 Abolished down-regulation of ClCKa/barttin channels by Nedd4-2 
Replacement of the tyrosine in the PY motif of barttin by alanine abolished the 
down-regulation of the ClC-Ka/barttin channels by Nedd4-2. Coexpression of 
Nedd4-2 with the mutant Y98Abarttin does not lead to significant reduction of 
channel activity (ICl = -0.91 ± 0.10 µA, n = 12) (Fig. 46) compared to expression 
of mutant Y98Abarttin alone (ICl = -1.08 ± 0.10 µA, n = 11). 
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Fig. 46. Nedd4-2 mediated down-regulation of ClCKa/barttin is abolished 
by elimination of the PY motif in Y98Abarttin. Xenopus laevis oocytes 
were injected with cRNA encoding ClC-Ka/barttin or ClC-Ka/Y98Abarttin 
with or without Nedd4-2. While the wild-type ClC-Ka/barttin is down-
regulated by Nedd4-2, the ClC-Ka/Y98Abarttin remains unaffected. (A) 
Original tracings. (B) Current-voltage relations. (C) Absolute current 
values at a holding voltage of -140 mV. Arithmetic means ± SEM (n = 
11-12). * indicates significant difference between the respective 
currents and the currents in oocytes expressing ClC-Ka/barttin alone. 
 
3.3.6 Immunolocalization of ClC-Ka and barttin channels 
Fig. 47 depicts the membrane expression of the ClC-Ka/barttin heterodimer. 
Fluorescence intensity is increased upon coexpression of SGK1 while Nedd4-2 
reduces the signal. The effect of Nedd4-2 is partially reversed by additional 
coexpression of SGK1. 
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Fig. 47. Immunolocalization of ClC-Ka and barttin in Xenopus oocyte 
membrane preparations. Membrane staining for ClC-Ka (red) and 
barttin (green) is detected in absence and presence of SGK1 but not 
in presence of Nedd4-2. Additional expression of SGK1 in oocytes 
injected with ClC-Ka, barttin and Nedd4-2 reconstitutes the 
membrane localization of ClC-Ka and barttin. 
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4.1 Regulation of the renal epithelial K+ channel ROMK1 
 
4.1.1 Up-regulation of K+ transport via ROMK1 by SGK1 and NHERF2 
The present experiments indicate that SGK1 alone is unable to up-regulate the 
ROMK1-mediated K+ current in Xenopus oocytes, consistent with earlier 
experiments performed on the closely related ROMK2 channel (Chen et al., 
1999). Interestingly, it appears that this lack of ROMK1 regulation is due to the 
requirement of NHERF2 expression for the SGK1 effect to be manifested. 
SGK1 has been shown to regulate the epithelial sodium channel (ENaC) in the 
absence of NHERF2 (Wagner et al., 2001). In fact, SGK1 stimulates ENaC by 
phosphorylating and thereby inhibiting the ubiquitin protein ligase Nedd4-2 in a 
PY motif-dependent manner (Debonneville et al., 2001). The ROMK1 sequence 
does not include a PY motif. On the other hand, ROMK1 has a PDZ binding 
motif at the COOH-terminus (Welling et al., 2001; Flagg et al., 2002), which is 
thought to be required for binding to NHERF2 (Yun et al., 2002a). The ENaC 
sequence does not include a PDZ binding motif, indicating that NHERF2 can 
not directly interact with ENaC. 
The stimulatory effect is not due to changes in ROMK1 channel I-V relation and 
gating properties (Fig. 19). In theory, SGK1/NHERF2 could have been effective 
through alterations of cytosolic pH, as coexpression of SGK1 with NHERF2 was 
shown to modulate the activity of the Na+/H+ exchanger 3 (NHE3) (Yun et al., 
2002a). NHE3 is expressed in Xenopus laevis oocytes intrinsically. However, 
the data showed that the intracellular pH was not significantly altered by the 
expression of SGK1 and NHERF2 ruling out this possibility. 
Instead, the combined action of SGK1 with NHERF2 enhances the abundance 
of ROMK1 in the plasma membrane, pointing to a stimulating effect on insertion 
or an inhibitory effect on the retrieval of the channel protein from the plasma 
membrane. These two possibilities could be discriminated by brefeldin A, a drug 
interfering with the insertion of membrane proteins (Pelham, 1991; Alvarez de la 
Rosa et al., 1999) as indicated in Fig. 48. In the presence of this drug, no further 
proteins can be inserted into the plasma membrane and the decay of channel 
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activity reflects solely the retrieval of channel proteins. The results demonstrate 
that the decay is significantly blunted by the combined expression of SGK1 and 
NHERF2 indicating that SGK1 and NHERF2 might affect ROMK1 at least in 
part by inhibition of protein retrieval. NHERF2 has previously been shown to link 
membrane proteins to cytoskeletal proteins such as ezrin and actin (Yun et al., 
1998; Takeda et al., 2001). It is hence plausible that the membrane expression 
of ROMK1 is stabilized by its linkage to the cytoskeleton via NHERF2. This may 
in part decrease the retrieval of ROMK1 or prolong the retention time at the cell 
membrane surface. 
 
retrieval
Brefeldin A
SGK1/NHERF2
ROMK 1
 
 
Fig.48. Brefeldin A inhibits the insertion of new ROMK1 channels into the 
plasma membrane and SGK1/NHERF2 delay the endocytotic 
retrieval of ROMK1 channels. 
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Even though the small shift of pH sensitivity cannot account for the marked 
enhancement of channel activity, it indicates that coexpression of NHERF2 or 
SGK1 does not only enhance channel abundance within the cell membrane but 
has a subtle but significant effect on channel properties. This effect is not due to 
enhanced protein abundance or channel activity, as the pH sensitivity was 
identical in oocytes injected with 5 ng or 20 ng of ROMK1 RNA despite the 
observed large differences in currents. Rather, SGK1 modifies the channel 
protein itself. In this respect, it may be of interest that the ROMK1 channel 
protein contains a consensus sequence for SGK1. 
The involvement of different proteins in the regulation of ROMK1 increases the 
plasticity of K+ channel regulation. One requirement for the up-regulation of 
ROMK1 by the SGK1/NHERF2 mechanism is the genomic up-regulation of 
SGK1. This up-regulation is accomplished by aldosterone (Chen et al., 1999; 
Cowling and Birnboim, 2000), cell shrinkage (Waldegger et al., 1997) and a 
wide variety of additional facto rs (Lang and Cohen, 2001). Expressed SGK1 
requires activation, which can be accomplished by insulin and IGF-1 through 
PI3-kinase and PDK1 (Kobayashi and Cohen, 1999b; Park et al., 1999). Thus, 
SGK1 integrates the signals coming from aldosterone on the one hand and 
insulin or IGF-1 on the other (Wang et al., 2001). The involvement of NHERF2 
adds to the complexity of this system. In particular, observed variability in K+ 
excretion in response to mineralocorticoids could be influenced by NHERF2 
activity or expression levels, hence accounting for the variability in hypokalemia 
seen in patients with primary aldosteronism (Gordon et al., 1994). A well 
described function of NHERF2 has been the regulation of the Na+/H+ exchanger 
NHE3, pointing to a role of this molecule in the regulation of the acid-base 
balance (Yun et al., 1997; Zerangue et al., 1999). Renal K+ excretion is a 
function of acid-base balance (Giebisch, 1998), a correlation attributed to the 
exquisite sensitivity of ROMK1 to cytosolic pH (Tsai et al., 1995; Fakler et al., 
1996; Kunzelmann et al., 2000; Leipziger et al., 2000). In face of the present 
observations, it is appealing to speculate that NHERF2 participates in the 
regulation of K+ excretion by acid-base balance. In any case, the effects of 
NHERF2 are not limited to the regulation of NHE3. Most recently, NHERF2 has 
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been shown to direct the signaling of the PTH receptor (Mahon et al., 2002), an 
observation further illustrating the diversity of NHERF2 functions. 
 
4.1.2 Determination of pH sensitivity of ROMK1 channel by SGK1 
As shown previously, the coexpression of the serum and glucocorticoid 
inducible kinase SGK1 and the Na+/H+ exchanger regulating factor NHERF2 
markedly increases the activity of the renal outer medullary K+ channel ROMK1. 
In the absence of NHERF2, SGK1 is unable to stimulate ROMK1 or ROMK2. 
The present observations further confirm the significant shift of the pH 
sensitivity of ROMK1 upon stimulation with SGK1. 
According to the present results, the shift of the ROMK1 pH sensitivity following  
coexpression of SGK1 is dependent on the intact consensus sequence in the 
ROMK1 channel protein and does not require the presence of NHERF2. 
Introduction of a negative charge in form of aspartate mimicking the negative 
charge of phosphoserine leads to a similar shift of pH sensitivity of the ROMK1 
channel. This observation is highly suggestive of the involvement of 
phosphorylation at serine44 in the shift of pH sensitivity. Earlier studies have  
identified several amino acid residues involved in the tuning of ROMK1 pH 
sensitivity (Fakler et al., 1996; Choe et al., 1997; McNicholas et al., 1998; 
Schulte et al., 1999). Lysine80 was first identified as the structural element 
necessary for pH-dependent gating. pH gating of ROMK1 is driven by titration of 
the lysine residue, i.e. protonation of the eNH2 group is a preequisite for 
channel inacti vation. Later studies (Schulte et al., 1999) demonstrated that an 
Arg41-Lys80-Arg311 triad controls ROMK1 pH sensitivity. The positively 
charged arginines establish a local field repelling hydrogen ions from the amino 
group of the Lys residue. Thus, the introduction of a negative charge at the 
Ser44 neighboring the Arg41-Lys80-Arg311 triad may modulate pH gating. 
Interestingly, the effect of SGK1 on pH sensitivity does not require the presence 
of NHERF2. Thus, it appears that NHERF2 is not required for phosphorylation 
of ROMK1 by SGK1. It should further be noted that introduction of aspartate 
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leads to a much more profound shift of the pH sensitivity than coexpression of 
SGK1 with or without NHERF2. 
The present observations further indicate that replacement of serine44 by either 
alanine or aspartate has profound effects on the maximal activity. Serine44 is 
one of the three PKA phosphoryla tion sites present in ROMK1 (Yoo et al., 
2003). All three sites must be phosphorylated for full channel function. While 
phosphorylation of the two COOH-terminal sites (serine219 and serine313) is 
required to maintain the channel in a high open probability state, serine44 
seems to control ROMK1 channel abundance in the plasma membrane. The 
markedly different maximal activity of the three ROMK1 mutants (S44DROMK1 > 
wild type ROMK1 > S44AROMK1) supports the hypothesis that serine44 is 
important for the trafficking of ROMK1 to the cell membrane. 
However, the effects of phosphorylation at serine44 on pH sensitivity and 
maximal current are not intimately linked but can be dissociated, pointing to 
additional factors in their regulation. Coexpression of S422DSGK1 without 
NHERF2 does not significantly increase maximal channel activity even though it 
leads to a shift of pH sensitivity. Thus, under these experimental conditions, 
phosphorylation of serine44 is apparently not sufficient to enhance ROMK1 
activity. Similarly, no (Chen et al., 1999; Yun et al., 2002b) or only moderate 
(Yoo et al., 2003) stimulation of ROMK1 has been observed earlier in the 
absence of NHERF2. In contrast, the maximal current of S44DROMK1 is 
markedly enhanced even in the absence of NHERF2. It should be kept in mind 
that the shift of pH sensitivity is significantly larger for S44DROMK1 than for 
coexpression of wild type ROMK1 with S422DSGK1. Thus, the impact of 
aspartate appears to be larger than the impact of serine-phosphorylation, 
explaining why the mutation of serine44 has a significantly larger effect on 
maximal current than phosphorylation. The presence of NHERF2 appears to 
enhance the trafficking without influencing the phosphorylation. Moreover, the 
effect of NHERF2 does not require phosphorylation of ROMK1. On the other 
hand, it requires the presence of SGK1, since coexpression of NHERF2 alone 
does not significantly up-regulate ROMK1. Thus, the effect of SGK1 is not 
exclusively due to phosphorylation of ROMK1. In any case, SGK1 modifies 
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ROMK1 activity by at least two distinct mechanisms: a shift of the pH sensitivity 
dependent on the negative charge at serine44 and a stimulation of maximal 
current favoured by but not dependent on the negative  charge at serine44. 
The stimulating effect of SGK1 on the activity of the epithelial Na+ channel 
ENaC (Chen et al., 1999; Wagner et al., 2001) is not sensitive to site directed 
modification of the SGK1 consensus sequence in the ENaC channel protein. 
Instead, it is mediated by phosphorylation and inhibition of the ubiquitin protein 
ligase Nedd4-2 (Debonneville et al., 2001; Snyder et al., 2002). Besides ENaC 
and ROMK1, several transporters and  channels have been shown to be 
regulated by SGK1, including the K+ channels  KCNE1/KCNQ1 (Embark et al., 
2002) and Kv1.3 (Gamper et al., 2002a, b; Wärntges et al., 2002), the voltage 
gated Na+ channel SCN5A (Boehmer et al., 2003b), the Na+/H+ exchanger 
NHE3 (Yun et al., 2002a), the glutamine transporter SN1 (Boehmer et al., 
2003a) and the Na+,K+-ATPase (Henke et al., 2002; Setiawan et al., 2002). 
There is little doubt that additional transport proteins will be added in near 
future. For none of these channels or carriers, phosphorylation of the channel 
protein by SGK1 has been shown. The requirement for NHERF2 has hitherto 
only been shown for ROMK1 (Yun et al., 2002b) and NHE3 (Yun et al., 2002a). 
The present observations demonstrate that at least two distinct molecular 
mechanisms may participate in the SGK1 dependent regulation of one channel 
protein, i.e. alteration of the channel properties by direct phosphorylation of the 
channel protein and increase of channel protein abundance in the cell 
membrane facilitated by but not dependent on channel phosphorylation. 
 
4.1.3 Stimulation of ROMK1 requires PDZ domains of NHERF2 
The present experiments confirm the previous observations disclosing a 
stimulating effect of the serum and glucocorticoid inducible kinase SGK1 and 
the Na+/H+ exchanger regulating factor NHERF2 on the renal outer medullary 
K+ channel ROMK1. While SGK1 alone is unable to stimulate ROMK1 (Yun et 
al., 2002b) or ROMK2 (Chen et al., 1999), the kinase is a potent stimulator of 
ROMK1 in the presence of NHERF2. 
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As shown in this study, to be effective NHERF2 requires an intact second PDZ 
domain. NHERF2 is thought to link membrane proteins to cytoskeletal proteins 
such as ezrin and actin, an effect accomplished by PDZ domains (Yun et al., 
1998; Takeda et al., 2001). The binding to the cytoskeleton may serve to target 
or stabilize the protein in the cell membrane. It further show the requirement for 
the PDZ binding motif at the COOH-terminus of ROMK1. 
In contrast to regulation of ROMK1 by SGK1, the well described stimulating 
effect of SGK1 on the activity of the epithelial Na+ channel ENaC (Chen et al., 
1999; Náray-Fejes-Tóth et al., 1999; Shigaev et al., 2000; Alvarez de la Rosa et 
al., 1999; Boehmer et al., 2000; Lang et al., 2000; Wagner et al., 2001; Loffing 
et al., 2001b) does not require the presence of NHERF2 but is mediated by 
inhibition of the ubiquitin protein ligase Nedd4-2 (Debonneville et al., 2001; 
Snyder et al., 2002). The involvement of Nedd4-2 in the SGK1 dependent 
regulation of ENaC and of NHERF2 in the SGK1 dependent regulation of 
ROMK1 allow some dissociation of renal tubular Na+ reabsorption and K+ 
secretion. In principal cells , ROMK1 maintains the electrical driving force for 
apical Na+ entry through ENaC and the depolarization of the apical membrane 
by Na+ entry through ENaC drives K+ secretion (Giebisch, 1998; Wang, 1999). 
Thus, mineralocorticoid stimulation of Na+ reabsorption is in general paralleled 
by stimulation of K+ secretion (Wright and Giebisch, 1992). However, 
maintenance of both, adequate extracellular fluid volume and equilibrated K+ 
balance, can be achieved only, if the relation of Na+ reabsorption and K+ 
secretion is not fixed. 
Finally, despite the fact that SGK1 is able to directly stimulate ROMK1 activity, it 
is safe to suggest that ROMK1 is stimulated by the concerted action of SGK1 
and NHERF2 (Fig. 49). The stimulatory effect requires the second PDZ domain 
of NHERF2 and the PDZ binding motif of ROMK1. 
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Fig.49. Role of SGK1 in the regulation of Na+ reabsorption and K+ 
secretion in principal cells of the collecting duct. Aldosterone 
stimulates the transcription and expression of SGK1. The inactive 
SGK1i requires activation to SGK1a, e.g. by insulin-like growth factor 1 
(IGF-1). SGK1a then enhances the  activity of the Na+ channel ENaC 
and K+ channel ROMK1 in the luminal cell membrane and of the 
Na+,K+-ATPase in the basolateral cell membrane. The regulation of 
ENaC is accomplished by inhibition of the ubiquitin ligase Nedd4-2, the 
regulation of ROMK1 requires the cooperation with the Na+/H+ 
exchanger regulating factor NHERF2. 
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4.2 Regulation of Ca2+ entry via TRPV5 by SGKs and NHERF2 
The present observations clearly demonstrate that expression of TRPV5 
induces Ca2+ influx allowing the cellular accumulation of Ca2+ and generating a 
Ca2+ current. In the presence of Cl-, Ca2+ entry through TRPV5 generates 
further currents (Hoenderop et al., 1999c) by activation of endogeneous Ca2+ 
sensitive Cl- channels (Callamaras and Parker, 2000). More importantly, the 
present observations disclose a completely novel mechanism regulating TRPV5 
activity, i.e. the regulation by two members of the serum and glucocorticoid 
inducible kinase family and the NHE regulating factor NHERF2. The effect of 
SGK1 depends on an intact catalytic subunit as the inactive mutant K127NSGK1 
does not influence TRPV5 even in the presence of NHERF2. Thus, the kinases 
are obviously effective through phosphorylation of target proteins. The 
stimulating effect is shared by SGK1 and SGK3, but not by SGK2 or PKB. The 
TRPV5 stimulating capacity correlates with the ability of the two kinases to bind 
NHERF2 (Yun et al., 2002a). In contrast to SGK1 and SGK3, SGK2 does not 
bind NHERF2 (Yun et al., 2002a) and is, according to the present study, not 
able to stimulate TRPV5. PKB is similarly not able to stimulate TRPV5. A well 
known function of SGK1 is its participation in the regulation of the epithelial Na+ 
channel ENaC (Chen et al., 1999; Náray-Fejes-Tóth et al., 1999; Alvarez de la 
Rosa et al., 1999; Shigaev et al., 2000; Lang et al., 2000; Wagner et al., 2001). 
SGK1 is effective by increasing the abundance of the ENaC protein within the 
cell membrane (Alvarez de la Rosa et al., 1999; Loffing et al., 2001; Wagner et 
al., 2001). Most recently, SGK1 has been shown to up-regulate the voltage 
gated K+ channel Kv1.3 (Gamper et al., 2002a, b; Wärntges et al., 2002), the 
epithelial Na+/H+ exchanger NHE3 (Yun et al., 2002) and the renal epithelial K+ 
channel ROMK1 (Yun et al., 2002b). Similar to SGK-dependent regulation of 
TRPV5, the regulation of ROMK1 by SGK1 has been shown to depend on 
NHERF2 (Yun et al., 2002b). The present study shows that the TRPV5 carboxy-
tail interacts with NHERF2 and, to be effective, NHERF2 requires an intact 
second PDZ domain. Similar to ROMK1, the sequence of TRPV5 has a PDZ 
binding motif. In contrast to the regulation of TRPV5 and NHE3 and  ROMK1, 
the regulation of ENaC or Kv1.3 does not require the participation of NHERF2. 
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SGK1 stimulates ENaC by phosphorylating the ubiquitin protein ligase Nedd4-2 
in a PY motif-dependent manner (Debonneville et al., 2001; Snyder et al., 
2002). The phosphorylation impedes the binding of Nedd4-2 to ENaC 
(Debonneville et al., 2001). The ENaC sequence does not include a PDZ 
binding motif, suggesting that NHERF2 can not directly interact with ENaC. As 
NHERF2 regulates both, TRPV5 and NHE3, it may participate in the link of 
TRPV5 activity and acid-base balance. TRPV5 displays an exquisite H+ 
sensitivity (Hoenderop et al., 1999c; Akutsu et al., 2001; Hoenderop et al., 
2002). Its activity is markedly reduced by lowering of the ambient pH. The 
sensitivity of renal tubular Ca2+ transport to H+ is of physiological significance, 
as on the one hand mineralization of bone depends on the deposition of Ca2+ 
salts (Bushinsky and Krieger, 1992) and on the other precipitation of Ca2+ 
phosphate salts is favoured by alkalinization of urine (Pak, 1992). Most recently, 
NHERF2 has been shown to direct the signaling of the PTH receptor (Mahon et 
al., 2002). Since PTH is a key regula tor of TRPV5 (Hoenderop et al., 2002), this 
effect may similarly contribute to the regulation of TRPV5. However, according 
to the present observations, NHERF2 alone is unable to activate TRPV5 but 
requires the additional action of SGK1 or of one of its isoforms. SGK1 
expression is highly variable, as it is up-regulated by glucocorticoids (Webster 
et al., 1993), aldosterone (Chen et al., 1999; Náray-Fejes-Tóth et al., 1999; 
Brennan and Fuller, 2000; Cowling and Birnboim, 2000; Shigaev et al., 2000), 
cell shrinkage (Waldegger et al., 1997) and a wide variety of additional factors 
(Lang and Cohen, 2001). Notably, SGK1 is under transcriptional control of 
1,25(OH)2D3 (Akutsu et al., 2001). It is thus tempting to speculate that SGK1 
participates in the regulation of TRPV5 by 1,25(OH)2D3 and PTH. Activation of 
SGK1 can be accomplished by insulin and IGF-1 through PI3-kinase and PDK1 
(Kobayashi and Cohen, 1999b; Park et al., 1999). SGK1 integrates the signals 
coming from genomic regulators on the one hand and insulin or IGF-1 on the 
other (Wang et al., 2001). Thus, activation of SGK1 may contribute to the 
stimulating effect of both, 1,25(OH)2D3 and IGF-1 on intestinal Ca2+ absorption 
(Bouillon, 1991). 
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Finally, TRPV5 is the target of a complex regulating mechanism invo lving both, 
the NHE regulating factor NHERF2 and the serum and glucocorticoid inducible 
kinase isoforms SGK1 and SGK3 (Fig. 50). The concerted action of NHERF2 
and the kinases markedly up-regulates the activity of this key channel in the 
regulation of Ca2+ homeostasis. 
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Fig.50. Proposed transport model of ECaC1 (TRPV5) regulated by SGK1 
and NHERF2. The PDZ domains of NHERF2 interact with the carboxy-
terminal of ECaC1 (TRPV5) as well as with the carboxy-terminal of 
SGK1. NHERF2 brings SGK1 into close proximity of ECaC1 (TRPV5) 
for phosphorylation and activation of channel activity. 
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4.3 Regulation of Cl- transport via CIC-Ka/barttin by SGKs and Nedd4-2 
The present observations disclose a novel mechanism in the regulation of the 
renal epithelial Cl- channel composed of ClC-Ka and barttin. Similar to what has 
been shown for the epithelial Na+ channel ENaC (Debonneville et al., 2001; 
Snyder et al., 2002), Nedd4-2 down-regulates ClC-Ka/barttin, an effect reversed 
by SGK1 and SGK3. Similar to ENaC (Debonneville et al., 2001; Snyder et al., 
2002), barttin carries a PY motif (Estévez et al., 2001) which is important for its 
interaction with the ubiquitin ligase. As a matter of fact, elimination of the PY 
motif abolishes the down-regulation of ClC-Ka by Nedd4-2. The stimulatory 
effect of SGK1 and SGK3 on the ClC-Ka/barttin channel complex in the 
absence of coinjected Nedd4-2 cRNA could be explained by inhibition of an 
endogeneous Nedd4-2. Xenopus oocytes do express low levels of both Nedd4-
2 and SGK1 (Boehmer et al., 2003b) which presumably participate in the 
regulation not only of endogeneous cell membrane proteins but as well of 
heterologously expressed channels and carriers. 
An obvious requirement for the physiological significance of the observed 
regulation is the coexpression of the channels with Nedd4-2 and the kinases. 
SGK1 is expressed mainly in the collecting duct system (Loffing et al., 2001b) 
but may under pathophysiological conditions be expressed in further nephron 
segments such as thick ascending limb (Lang et al., 2000). Barttin is expressed 
thoughout the distal nephron, i.e. medullary and cortical thick ascending limb, 
distal convoluted tubule, connecting tubule, cortical and medullary collecting 
duct (Waldegger et al., 2002). ClC-K1 and ClC-K2, the rat homologues of 
human ClC-Ka and ClC-Kb are similarly localized in all distal nephron segments 
(Waldegger et al., 2002). 
As SGK1 is under transcriptional control of glucocorticoids (Webster et al., 
1993; Brennan and Fuller, 2000) and mineralocorticoids (Chen et al., 1999; 
Náray-Fejes-Tóth et al., 1999; Cowling and Birnboim, 2000; Shigaev et al., 
2000) and is activated by insulin and IGF-1 (Kobayashi and Cohen, 1999b), the 
present mechanism may well participate in the regulation of renal tubular Cl- 
transport by those hormones. 
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The functional significance of the regulation by SGK1 is reflected by the SGK1 
knockout mouse (SGK1-/-). NaCl excretion by this mouse is normal under salt 
repletion and is decreased during salt deficient diet (Wulff et al., 2002). 
However, the adaptation following salt free diet is insufficient, i.e. the Na+ and 
Cl- excretion remains significantly higher in the SGK1-/- mouse as compared to 
its wild-type littermate (SGK1+/+). As a result, in contrast to the SGK1+/+ 
mouse, the SGK1-/- mouse suffers from weight loss, decline in blood pressure 
and decrease of renal glomerular filtration rate at low salt diet (Wulff et al., 
2002). Those changes do occur despite a larger increase of plasma aldosterone 
concentration in the SGK1-/- mouse as compared to the SGK1+/+ mouse (Wulff 
et al., 2002). The renal NaCl loss is at least partially due to insufficient up-
regulation of ENaC in the cell membrane but according to the results of the 
present study may be paralleled by defective regulation of Cl- channels.  
Finally, the present observations disclose a novel mechanism of Cl- channel 
regulation and a novel target for regulation by the ubiquitin ligase Nedd4-2 (Fig. 
51) and the serum and glucocorticoid inducible kinase isoforms SGK1 and 
SGK3 (Fig. 52). 
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Fig.51. Proposed organization of proteins involved in the Nedd4-2-
dependent regulation of CIC-Ka/barttin channels. Nedd4-2 is a 
cytosolic protein. Upon a rise in cytosolic [Ca2+], Nedd4-2 is moblizied 
to the apical membrane via its C2 domain. Once there, it binds the 
barttin-PY motif via its WW domains, allowing ubiquitination of the 
channel by Hect domain, wich facilitates channel endocytosis and 
lysosomal degradation. Thus, Nedd4-2 is involved in regulating ClC-
Ka/barttin stability at the cell surface. 
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Fig.52. SGK1 regulates Nedd4-2. SGK1 binds via its PY motif to the WW 
domains of Nedd4-2. This interaction leads to the phosphorylation of 
serine444 and, to a lesser extent, serine338, which in turn reduces the 
affinity of Nedd4-2 towards target protein. Conseqently, target protein 
becomes less ubiquitinated, leading to accumulation of target protein at 
the cell surface. This accumulation may be due to either increased 
insertion of protein at the cell surface or reduced internalization, or 
both. 
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Summary 
The Serum and Glucocorticoid induced protein Kinase (SGK) is a member of 
the serine/threonine protein kinase gene family and is activated by 
phosphorylation in response to signals that stimulate phosphatidylinositide 3-
kinase (PI3-kinase). This process is mediated by 3-phosphoinositide-dependent 
protein kinase 1 (PDK1). Two additional isoforms of SGK have been identified, 
termed SGK2 and SGK3. SGK (1-3) are all strongly activated by 
phosphorylation in response to oxidative stress (e.g. H2O2) and insulin-like 
growth factor 1 (IGF-1). SGK1 RNA is induced in response to serum and/or 
glucocorticoids, aldosterone, high extracellular osmolarity and transforming 
growth factor beta (TGF-b). 
The putative role of SGK1 and its isoforms in the regulation of renal ion 
channels implicated for potassium, calcium and chloride transport has been 
examined. In kidney, SGK1 transcript levels were excessively high in the distal 
tubule and collecting duct epithelial cells. SGK1 transcripts were also detected 
in thick ascending limb epithelial cells, when glucose concentrations are high. 
NHERF2 and SGK1 interact to enhance ROMK1 activity in large part by 
enhancing the abundance of channel protein within the cell membrane. SGK1 
interacts with NHERF2 through the second PDZ domain of NHERF2. Deletion 
of the second PDZ domain or of the putative PDZ binding motif on ROMK1 
abolishes channel stimulation. This interaction allows the integration of genomic 
regulation and activation of SGK1 and NHERF2 in the control of ROMK1 activity 
and renal K+ excretion. Phosphorylation by SGK1 or introduction of negative 
charge at serine44 shifts the pH sensitivity of the channel and contributes to the 
stimulation of maximal channel activity by the  kinase. 
Furthermore, the effect of serum and glucocorticoid induced kinase (SGK) 
isoforms and NHE3 regulating factor 2 (NHERF2) on epithelial calcium channel 
ECaC1 (TRPV5) has also been examined. Since coexpression of SGK1 or 
SGK3 and NHERF2 leads to stimulation of ECaC1 determined by measurement 
of Ca2+ dependent chloride current as well as radioactively labelled Ca2+ uptake, 
SGK2 and protein kinase B (PKB) failed to enhance ECaC1 irrespective of 
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NHERF2. Since the stimulating effect of SGK1 and NHERF2 on ECaC1 is 
abolished by ruthenium red and absent in the presence of ionomycin, it can be 
concluded that ECaC1 is stimulated in a direct way. Interaction of SGK1 and 
NHERF2 is then extensively studied by generating constitutively active 
S422DSGK1, and the inactive form K127NSGK1. S422DSGK1 but not K127NSGK1 can 
mimic the stimulating effect of wild type SGK1 coinjected with NHERF2. The 
kinase inhibitor chelerythrine (10 µM) inhibits ECaC1 activity. 
Moreover, pull-down assay shows the interaction of the carboxy-tail of ECaC1 
and NHERF2 whereas functional experiments show the abolishment of the 
stimulatory effect of SGK1 and NHERF2 who’s second PSD 95/Drosophila disk 
large/ZO-1 (PDZ) domain has been deleted. It is thus concluded, that SGK1 
stimulates ECaC1 by interaction with the second PDZ domain of NHERF2. 
NHERF2 then binds to the carboxy-tail of ECaC1 rendering a stabilization of 
ECaC1 by mediating interaction with actin cytoskeleton via ezrin. 
Finally, the effect of serum and glucocorticoid induced kinase (SGK) isoforms 
and ubiquitin ligase Nedd4-2 on renal epithelial Cl- channel (CIC-Ka/barttin) has 
also been studied. Expression of ClC-Ka/barttin induces a slightly inwardly 
rectifying current which is significantly decreased upon coexpression of Nedd4-
2. The coexpression of S422DSGK1, SGK1 or SGK3, but not of SGK2 or 
K127NSGK1 significantly stimulated the current and reversed the effect of Nedd4-
2. The down-regulation of ClC-Ka/barttin is abolished by elimination of the PY 
motif in ClC-Ka/Y98Abarttin. The present observations disclose a novel 
mechanism regulating ClC-Ka which presumably participates in the regulation 
of transport in kidney and inner ear. 
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Zusammenfassung 
Die Serum und Glucocorticoid-abhängige Protein-Kinase (SGK) ist eine 
Serin/Threonin-Proteinkinase, die über eine Signalkaskade via 
Phosphatidylinositide 3-Kinase (PI3-kinase) und 3-Phosphoinositid-abhängige 
Proteinkinase 1 (PDK1) phosphoryliert und damit aktiviert wird. Auf gleichem 
Wege werden die später entdeckten Isoformen der SGK, die SGK2 und SGK3 
aktiviert. Über den genannten Signalweg stimuliert insulin-like growth factor 1 
(IGF-1) die drei Kinasen. Darüberhinaus werden sie durch oxidativen Stress 
aktiviert. Die Transkription der SGK1, nicht aber der SGK2 und SGK3, wird 
durch Serum, Glucocorticoide, Aldosteron, hohe extrazelluläre Osmolarität und 
transforming growth factor beta (TGF-b) gesteigert. 
Die mutmaßliche Rolle der SGK1 und seiner Isoformen SGK2 und SGK3 in der 
Regulation renaler Ionenkanäle, die für Kalium-, Kalzium- und Chloridtransport 
verantwortlich sind, ist untersucht worden. In der Niere ist das SGK1 
Expressionsniveau in Epithelzellen des distalen Tubulus und des Sammelrohrs 
sehr hoch. Bei hohen Glukosekonzentrationen werden SGK1 Transkripte auch 
im aufsteigenden Ast der Henle -Schleife nachgewiesen. 
NHERF2 und SGK1 interagieren miteinander und steigern damit die ROMK1 
Aktivität, indem sie vor allem die Anzahl der Ionenkanäle in der Zellmembran 
erhöhen. Dabei interagiert SGK1 mit NHERF2 über dessen zweite PDZ 
Domäne. Eine Deletion der zweiten PDZ Domäne oder der vermeintlichen PDZ 
Bindungsstelle im ROMK1 Protein verhindert die Kanalstimulation. Diese 
Interaktion erlaubt die Integration genomischer Regulation und Aktivierung 
durch SGK1 und NHERF bei der Kontrolle der ROMK1 Aktivität und der renalen 
Kaliumausscheidung. 
Ferner wurde die Wirkung von Serum und Glucocorticoid induzierten Kinase 
(SGK) Isoformen und NHE3 Regulating Factor 2 (NHERF2) auf den epithelialen 
Kalcium Kanal (ECaC1) untersucht. Während SGK1 und SGK3 und NHERF2 
eine ECaC1 Stimulierung, die durch den Ca2+-abhängingen Chloridstrom sowie 
die radioaktiv markiertes Ca2+ Aufnahme bestimmt wird, zeigen, haben SGK2 
und Protein kinase B (PKB) unabhängig von NHERF2 keinen solchen Effekt. 
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Die konstitutiv aktive Form S422DSGK1 und die inaktive K127NSGK1 wurden 
hergestellt. S422DSGK1 aber nicht K127NSGK1 zusammen mit NHERF2 verfügt 
immer noch über die Stimulationswirkung auf ECaC1. Der Kinase-hemmer 
Chelerythrin (10 µM) inhibiert die Aktivität von ECaC1. 
Pull-down Assays zeigen die Interaktion vom Carboxy-Ende des ECaC1 mit 
NHERF2, während funktionelle Experimente die Herabsetzung der 
Stimulationswirkung von SGK1 und einer NHERF2 mit deletierter zweiter PDZ 
Domäne zeigen. Die Schlussfolgerung ist, dass SGK1 ECaC1 durch Interaktion 
mit dem zweiten PDZ Domain von NHERF2 stimuliert. NHERF2 bindet an das 
Carboxy-Ende Tail von ECaC1, welches ECaC1 dadurch mit dem Aktin 
Zytoskellet stabilisiert. 
Letztendlich wurde zudem der Effekt der SGK Isoformen und der Ubiquitin 
Ligase Nedd4-2 auf den renalen, epithelialen Chloridkanal (ClC-Ka/barttin)  
untersucht. Expression von ClC-Ka/barttin verursacht einen schwach einwärts 
gleichrichtenden Strom, der signifikant durch die Koexpression von Nedd4-2 
herabgesetzt wird. Die Koexpression von S422DSGK1, SGK1 oder SGK3, aber 
nicht die Koexpression von SGK2 oder K127NSGK1, stimulierte den Strom 
signifikant beziehungsweise hob teilweise den Effekt von Nedd4-2 auf. Die 
Herrunterregulation von ClC-Ka/Y98Abarttin wird durch die Elimination des PY 
Motifs im ClC-Ka/Y98Abarttin aufgehoben. Die vorliegenden Beobachtungen 
legen einen neuen Regulationsmechanismus für ClC-Ka offen, der 
höchstwahrscheinlich in der Transportregulation in der Niere und im Innenohr 
beteiligt ist. 
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